Bunge Global 10-Q30 Oct 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2024	Oct. 25, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	000-56607
Entity Registrant Name	BUNGE GLOBAL SA
Entity Incorporation, State or Country Code	V8
Entity Tax Identification Number	98-1743397
Entity Address, Address Line One	Route de Florissant 13
Entity Address, Postal Zip Code	1206
Entity Address, City or Town	Geneva
Entity Address, Country	CH
City Area Code	314
Local Phone Number	292-2000
Title of 12(b) Security	Registered Shares, $0.01 par value per share
Trading Symbol	BG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		139,627,104
Entity Central Index Key	0001996862
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 12,908	$ 14,227	$ 39,566	$ 44,604
Cost of goods sold	(12,136)	(13,182)	(37,254)	(41,013)
Gross profit	772	1,045	2,312	3,591
Selling, general and administrative expenses	(437)	(447)	(1,325)	(1,220)
Interest income	33	38	112	121
Interest expense	(127)	(133)	(358)	(374)
Foreign exchange (losses) gains – net	14	(47)	(101)	(64)
Other income (expense) – net	87	8	212	35
Income (loss) from affiliates	(20)	39	(58)	83
Income (loss) before income tax	322	503	794	2,172
Income tax (expense) benefit	(89)	(114)	(236)	(495)
Net income (loss)	233	389	558	1,677
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(12)	(16)	(23)	(50)
Net income (loss) attributable to Bunge shareholders (Note 18)	$ 221	$ 373	$ 535	$ 1,627
Earnings per share—basic (Note 18)
Net income (loss) attributable to Bunge shareholders - basic (in dollars per share)	$ 1.57	$ 2.50	$ 3.77	$ 10.85
Earnings per share—diluted (Note 18)
Net income (loss) attributable to Bunge shareholders - diluted (in dollars per share)	$ 1.56	$ 2.47	$ 3.73	$ 10.71

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 233	$ 389	$ 558	$ 1,677
Other comprehensive income (loss):
Foreign exchange translation adjustment	167	(166)	(369)	102
Unrealized gains (losses) on designated hedges, net of tax (expense) benefit of $(1) and $1 in 2024 and $1 and $(2) in 2023	(57)	31	68	(61)
Reclassification of net (gains) losses to net income, net of tax expense (benefit) of $1 and $1 in 2024 and $3 and $2 in 2023	(1)	(2)	(2)	101
Total other comprehensive income (loss)	109	(137)	(303)	142
Total comprehensive income (loss)	342	252	255	1,819
Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(29)	(12)	(20)	(45)
Total comprehensive income (loss) attributable to Bunge	$ 313	$ 240	$ 235	$ 1,774

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Unrealized gains (losses) on designated hedges, tax benefit (expense)	$ (1)	$ 1	$ 1	$ (2)
Reclassification of net (gains) losses to net income, tax expense (benefit)	$ 1	$ 3	$ 1	$ 2

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,836	$ 2,602
Trade accounts receivable (less allowances of $91 and $104) (Note 4)	2,100	2,592
Inventories (Note 5)	7,465	7,105
Other current assets (Note 6)	3,518	4,051
Total current assets	15,919	16,350
Property, plant and equipment, net	5,115	4,541
Operating lease assets	937	926
Goodwill	482	489
Other intangible assets, net	358	398
Investments in affiliates	1,136	1,280
Deferred income taxes	725	773
Other non-current assets (Note 7)	595	615
Total assets	25,267	25,372
Current liabilities:
Short-term debt (Note 13)	755	797
Current portion of long-term debt (Note 13)	663	5
Trade accounts payable (includes $569 and $823 carried at fair value) (Note 11)	3,211	3,664
Current operating lease obligations	288	308
Other current liabilities (Note 10)	2,774	2,913
Total current liabilities	7,691	7,687
Long-term debt (Note 13)	4,777	4,080
Deferred income taxes	376	400
Non-current operating lease obligations	595	566
Other non-current liabilities (Note 16)	670	824
Redeemable noncontrolling interest	2	1
Equity (Note 17):
Registered shares, par value $.01; authorized not issued – 80,714,736 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2024 – 139,625,014 shares, 2023 – 145,319,668 shares	1	1
Additional paid-in capital	5,881	5,900
Retained earnings	12,231	12,077
Accumulated other comprehensive income (loss) (Note 17)	(6,354)	(6,054)
Treasury shares, at cost; 2024 - 21,804,458 shares and 2023 - 16,109,804 shares	(1,624)	(1,073)
Total Bunge shareholders’ equity	10,135	10,851
Noncontrolling interests	1,021	963
Total equity	11,156	11,814
Total liabilities, redeemable noncontrolling interest and equity	$ 25,267	$ 25,372

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Trade accounts receivable, allowances	$ 91	$ 104
Trade accounts payable at fair value	$ 569	$ 823
Registered shares, par value (in dollars per share)	$ 0.01	$ 0.01
Registered shares, authorized not issued (in shares)	80,714,736	80,714,736
Registered shares, conditionally authorized (in shares)	32,285,894	32,285,894
Registered shares, issued (in shares)	139,625,014	145,319,668
Registered shares, outstanding (in shares)	139,625,014	145,319,668
Treasury shares, at cost (in shares)	21,804,458	16,109,804

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES
Net income (loss)	$ 558	$ 1,677
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Impairment charges	36	56
Foreign exchange (gain) loss on net debt	39	(151)
Depreciation, depletion and amortization	345	317
Share-based compensation expense	49	51
Deferred income tax expense (benefit)	(43)	115
Results from affiliates	39	(100)
Other, net	48	65
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable	382	306
Inventories	(557)	933
Secured advances to suppliers	146	(228)
Trade accounts payable and accrued liabilities	(386)	(690)
Advances on sales	(179)	(227)
Net unrealized (gains) losses on derivative contracts	533	(247)
Margin deposits	(152)	(111)
Recoverable and income taxes, net	(148)	(19)
Marketable securities	7	(17)
Other, net	130	130
Cash provided by (used for) operating activities	847	1,860
INVESTING ACTIVITIES
Payments made for capital expenditures	(887)	(805)
Proceeds from investments	739	21
Payments for investments	(872)	(26)
Settlements of net investment hedges	(4)	(57)
Proceeds from beneficial interest in securitized trade receivables	0	85
Proceeds from disposals of businesses and property, plant and equipment	6	165
Proceeds from investments in affiliates	103	0
Payments for investments in affiliates	(23)	(136)
Other, net	(19)	107
Cash provided by (used for) investing activities	(957)	(646)
FINANCING ACTIVITIES
Net change in short-term debt with maturities of three months or less	113	161
Proceeds from short-term debt with maturities greater than three months	646	848
Repayments of short-term debt with maturities greater than three months	(765)	(593)
Proceeds from long-term debt	2,036	1,000
Repayments of long-term debt	(752)	(879)
Debt issuance costs	(24)	(25)
Repurchases of registered shares	(600)	(466)
Dividends paid to registered and common shareholders	(287)	(287)
Capital contributions from (Return of capital to) noncontrolling interest	41	40
Other, net	(32)	(12)
Cash provided by (used for) financing activities	376	(213)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash	0	40
Net increase (decrease) in cash and cash equivalents, and restricted cash	266	1,041
Cash and cash equivalents, and restricted cash - beginning of period	2,623	1,152
Cash and cash equivalents, and restricted cash - end of period	$ 2,889	$ 2,193

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS - USD ($) $ in Millions	Total	Redeemable Non- Controlling Interests	Registered Shares	Common Shares	Treasury Shares	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non- Controlling Interests
Beginning balance at Dec. 31, 2022		$ 4
Increase (Decrease) in Temporary Equity
Net income (loss)		(1)
Ending balance at Sep. 30, 2023		3
Beginning balance (in shares) at Dec. 31, 2022				149,907,932
Beginning balance (in shares) at Dec. 31, 2022					18,835,812
Beginning balance at Dec. 31, 2022	$ 9,956			$ 1	$ (1,320)	$ 6,692	$ 10,222	$ (6,371)	$ 732
Increase (Decrease) in Stockholders' Equity
Net income (loss)	1,678						1,627		51
Other comprehensive income (loss)	142							147	(5)
Dividends on shares	(290)						(290)
Dividends to noncontrolling interests on subsidiary common stock	(17)								(17)
Capital contribution (return) from (to) noncontrolling interest	40								40
Acquisition of noncontrolling interest	91								91
Share-based compensation expense	51					51
Repurchase of shares (in shares)				(4,327,536)	4,327,536
Repurchase of shares	(488)				$ (488)
Issuance of shares, including stock dividends (in shares)				787,907
Issuance of shares, including stock dividends	(20)					(16)	(4)
Ending balance (in shares) at Sep. 30, 2023				146,368,303
Ending balance (in shares) at Sep. 30, 2023					23,163,348
Ending balance at Sep. 30, 2023	11,143			$ 1	$ (1,808)	6,727	11,555	(6,224)	892
Beginning balance at Jun. 30, 2023		4
Increase (Decrease) in Temporary Equity
Net income (loss)		(1)
Ending balance at Sep. 30, 2023		3
Beginning balance (in shares) at Jun. 30, 2023				150,630,209
Beginning balance (in shares) at Jun. 30, 2023					18,835,812
Beginning balance at Jun. 30, 2023	11,358			$ 1	$ (1,320)	6,706	11,279	(6,091)	783
Increase (Decrease) in Stockholders' Equity
Net income (loss)	390						373		17
Other comprehensive income (loss)	(137)							(133)	(4)
Dividends on shares	(96)						(96)
Dividends to noncontrolling interests on subsidiary common stock	(2)								(2)
Capital contribution (return) from (to) noncontrolling interest	7								7
Acquisition of noncontrolling interest	91								91
Share-based compensation expense	17					17
Repurchase of shares (in shares)				(4,327,536)	4,327,536
Repurchase of shares	(488)				$ (488)
Issuance of shares, including stock dividends (in shares)				65,630
Issuance of shares, including stock dividends	3					4	(1)
Ending balance (in shares) at Sep. 30, 2023				146,368,303
Ending balance (in shares) at Sep. 30, 2023					23,163,348
Ending balance at Sep. 30, 2023	11,143			$ 1	$ (1,808)	6,727	11,555	(6,224)	892
Beginning balance at Dec. 31, 2023	1	1
Increase (Decrease) in Temporary Equity
Net income (loss)		(1)
Capital contribution (return) from (to) noncontrolling interest		2
Ending balance at Sep. 30, 2024	$ 2	2
Beginning balance (in shares) at Dec. 31, 2023			145,319,668
Beginning balance (in shares) at Dec. 31, 2023	16,109,804				16,109,804
Beginning balance at Dec. 31, 2023	$ 11,814		$ 1		$ (1,073)	5,900	12,077	(6,054)	963
Increase (Decrease) in Stockholders' Equity
Net income (loss)	559						535		24
Other comprehensive income (loss)	(303)							(300)	(3)
Dividends on shares	(380)						(380)
Dividends to noncontrolling interests on subsidiary common stock	(4)								(4)
Capital contribution (return) from (to) noncontrolling interest	39					(2)			41
Share-based compensation expense	49					49
Repurchase of shares (in shares)			(6,440,930)		6,440,930
Repurchase of shares	(600)				$ (600)
Issuance of shares, including stock dividends (in shares)			746,276		(746,276)
Issuance of shares, including stock dividends	$ (18)				$ 49	(66)	(1)
Ending balance (in shares) at Sep. 30, 2024			139,625,014
Ending balance (in shares) at Sep. 30, 2024	21,804,458				21,804,458
Ending balance at Sep. 30, 2024	$ 11,156		$ 1		$ (1,624)	5,881	12,231	(6,354)	1,021
Beginning balance at Jun. 30, 2024		1
Increase (Decrease) in Temporary Equity
Net income (loss)		(1)
Capital contribution (return) from (to) noncontrolling interest		2
Ending balance at Sep. 30, 2024	2	$ 2
Beginning balance (in shares) at Jun. 30, 2024			141,641,323
Beginning balance (in shares) at Jun. 30, 2024					19,788,149
Beginning balance at Jun. 30, 2024	10,984		$ 1		$ (1,427)	5,869	12,005	(6,446)	982
Increase (Decrease) in Stockholders' Equity
Net income (loss)	234						221		13
Other comprehensive income (loss)	109							92	17
Dividends on registered shares	5						5
Dividends to noncontrolling interests on subsidiary common stock	(1)								(1)
Capital contribution (return) from (to) noncontrolling interest	8					(2)			10
Share-based compensation expense	15					15
Repurchase of shares (in shares)			(2,063,956)		2,063,956
Repurchase of shares	(200)				$ (200)
Issuance of shares, including stock dividends (in shares)			47,647		(47,647)
Issuance of shares, including stock dividends	$ 2				$ 3	(1)	0
Ending balance (in shares) at Sep. 30, 2024			139,625,014
Ending balance (in shares) at Sep. 30, 2024	21,804,458				21,804,458
Ending balance at Sep. 30, 2024	$ 11,156		$ 1		$ (1,624)	$ 5,881	$ 12,231	$ (6,354)	$ 1,021

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical) - $ / shares	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Dividends on shares (in dollars per share)	$ 0.68	$ 0.68	$ 0.6625	$ 2.72	$ 1.95

BASIS OF PRESENTATION, PRINCIPL

BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Global SA ("Bunge" or the "Company"), its subsidiaries and variable interest entities ("VIEs") in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues, and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended ("Exchange Act"). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission ("SEC") rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2023 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2023, forming part of Bunge’s 2023 Annual Report on Form 10-K filed with the SEC on February 22, 2024. On November 1, 2023, Bunge Global SA completed the change of jurisdiction of incorporation of its group holding company from Bermuda to Switzerland (the "Redomestication"). The Redomestication, as approved by our shareholders, was effected pursuant to a scheme of arrangement under Bermuda law. Each common share of Bunge Limited, par value $0.01 per share, was cancelled in exchange for an equal number of registered shares of Bunge Global SA, par value $0.01 per share (the "registered shares"). The registered shares began trading on the New York Stock Exchange (the "NYSE") under the symbol "BG" on November 1, 2023, which is the same symbol under which the Bunge Limited shares were previously traded. References to the term "shares" refer to Bunge Limited common shares prior to the Redomestication and to Bunge Global SA registered shares after the Redomestication, unless otherwise specified. Cash, Cash Equivalents, and Restricted Cash Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the condensed consolidated statements of cash flows. The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows. (US$ in millions) September 30, 2024 September 30, 2023 Cash and cash equivalents $ 2,836 $ 2,173 Restricted cash included in Other current assets 53 20 Total $ 2,889 $ 2,193 Cash paid for inco me taxes , net of refunds received, was $333 million and $350 million for the nine months ended September 30, 2024, and 2023, respectively. Cash paid for interest expense was $357 million and $366 million for the nine months ended September 30, 2024, and 2023, respectively. New Accounting Pronouncements and Disclosure Rules In March 2024, the SEC adopted final climate-related disclosure rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. The rules require disclosure of governance, risk management, and strategy related to material climate-related risks as well as disclosure of material greenhouse gas emissions in registration statements and annual reports. In addition, the rules require presentation of certain climate-related disclosures in the annual consolidated financial statements. On April 4, 2024, the SEC voluntarily stayed the effective date of the final rules pending completion of judicial review following certain legal challenges. The rules are effective beginning with annual periods ending December 31, 2025, pending resolution of the stay. Bunge is currently evaluating the impact of the rules on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740) ("ASU 2023-09"). ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The new requirements apply to all entities subject to income taxes and will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company has begun evaluating disclosure presentation alternatives that will result in expanded disclosure in the Company's Income Taxes footnote. In November 2023, the FASB issued ASU 2023-07, Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280) ("ASU 2023-07"). The standard requires incremental disclosures related to reportable segments, including disaggregated expense information and the title and position of the company's chief operating decision maker, as identified for purposes of segment determination. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The Company has begun evaluating disclosure presentation alternatives that will result in expanded disclosure in the Company's Segment Information

ACQUISITIONS AND DISPOSITIONS

ACQUISITIONS AND DISPOSITIONS	9 Months Ended
ACQUISITIONS AND DISPOSITIONS	Sep. 30, 2024
Business Combination, Asset Acquisition And Discontinued Operations and Disposal Groups [Abstract]
ACQUISITIONS AND DISPOSITIONS	ACQUISITIONS AND DISPOSITIONS Acquisitions Viterra Limited Business Combination Agreement On June 13, 2023, Bunge entered into a definitive business combination agreement (the "Business Combination Agreement") with Viterra Limited ("Viterra") and its shareholders including certain affiliates of Glencore PLC, Canada Pension Plan Investment Board, and British Columbia Investment Management Corporation (collectively, the "Sellers"), to acquire Viterra in a stock and cash transaction (the "Acquisition"). Bunge shareholders approved the Acquisition at the Extraordinary General Meeting held October 5, 2023. The Acquisition of Viterra by Bunge will create an innovative global agribusiness company well positioned to meet the demands of increasingly complex markets and better serve farmers and end-customers. Under the terms of the Business Combination Agreement, Viterra shareholders are anticipated to receive approximately 65.6 million registered shares of Bunge, with an aggregate value of approximately $6.3 billion as of September 30, 2024 and receive approximately $2.0 billion in cash (collectively the "Transaction Consideration"), in return for 100% of the outstanding equity of Viterra. The determination of the final value of the Transaction Consideration will depend on the Company's share price at the time of closing. Upon completion of the transaction, the Sellers are expected to own approximately 30% of the combined Bunge company on a fully diluted basis, before giving effect to any share repurchases by Bunge occurring after June 13, 2023. In connection with the execution of the Business Combination Agreement, Bunge secured a total of $8.0 billion in acquisition debt financing ("Acquisition Financing"). On September 17, 2024, Bunge completed the sale and issuance of three tranches of unsecured senior notes ("Senior Notes") for an aggregate principal amount of $2.0 billion. See Note 13 - Debt for further information. As a result of the Senior Notes issuance, and in accordance with its terms, the Acquisition Financing commitment was reduced by $2.0 billion to $6.0 billion at September 30, 2024. Bunge intends to use a portion of the proceeds from the Acquisition Financing and Senior Notes issuance to fund a portion of the cash consideration for Bunge's Acquisition of Viterra and to repay a portion of certain Viterra debt to be assumed in connection with the Acquisition, including, in each case, related fees and expenses, and, with any remaining amounts, for general corporate purposes. Also, in the third quarter of 2024, Bunge's wholly-owned subsidiary, Bunge Limited Finance Corp. ("BLFC"), commenced offers (the "US Exchange Offers") to exchange all outstanding notes of certain series issued by Viterra Finance B.V. ("VFBV") and guaranteed by Viterra and Viterra B.V., for up to $1.95 billion aggregate principal amount of new notes issued by BLFC and guaranteed by Bunge. In addition, in the third quarter of 2024, Viterra commenced a consent solicitation (the "European Consent Solicitation") to amend the indenture governing VFBV's outstanding 500 million Euro aggregate principal amount of 0.375% senior unsecured notes due 2025 and outstanding 700 million Euro aggregate principal amount of 1.000% senior unsecured notes due 2028 to, among other things, substitute the issuer and guarantors of such notes with Bunge Finance Europe B.V. ("BFE"), a wholly owned finance subsidiary of Bunge, as issuer, and Bunge as guarantor. The US Exchange Offers and European Consent Solicitation are conditioned, among other things, upon the consummation of the Acquisition. See Note 13 - Debt for further information. The Acquisition is subject to the satisfaction of regulatory approvals and other customary closing conditions. The Acquisition is expected to receive the remaining regulatory approvals and close in the next several months. The Business Combination Agreement may be terminated by mutual written consent of the parties and includes certain customary termination rights. If the Business Combination Agreement is terminated in connection with certain circumstances relating to the failure to obtain certain antitrust and competition clearances that are conditions to closing, Bunge would be obligated to pay the Sellers a fee of $400 million in the aggregate. Additionally, on June 12, 2023 in contemplation of the Business Combination Agreement, Bunge Limited's Board of Directors approved a $1.7 billion expansion of the existing share repurchase program for the repurchase of Bunge's issued and outstanding shares. Approximately $300 million remained outstanding under the existing program prior to the expansion of the program, resulting in an aggregate program size of up to $2.0 billion of repurchases of Bunge's issued and outstanding shares. Since June 13, 2023, Bunge repurchased 11,848,791 shares for $1.2 billion. Therefore, as of September 30, 2024, $800 million remains outstanding for repurchases under the program. See Note 17 - Equity for further details on share repurchases. CJ Latam and Selecta Share Purchase Agreement On October 10, 2023, Bunge entered into a definitive share purchase agreement with CJ CheilJedang Corporation and STIC CJ Global Investment Corporate Partnership Private Equity Fund to acquire 100% of outstanding equity of CJ Latam Participações Ltda. and CJ Selecta S.A. (collectively, “CJ”) for a total cash consideration of approximately $510 million to be adjusted for net debt, plus an additional sum in consideration for the value of net working capital. Operations of CJ primarily consist of an oilseed processing facility located in Brazil. Bunge expects to finance the transaction through cash from operations and existing financing facilities. The acquisition is expected to close in late 2024, subject to customary closing conditions. Dispositions BP Bunge Bioenergia On June 19, 2024, Bunge entered into a definitive share purchase agreement with BP Biofuels Brazil Investment Limited ("BP") to sell its 50% ownership share in BP Bunge Bioenergia, a joint venture formed to cultivate sugar cane, produce and sell sugar and sugar ethanol, and create power cogeneration activities. On October 1, 2024, the transaction closed in accordance with the terms of the share purchase agreement for an approximate total net amount of $828 million in consideration inclusive of certain closing adjustments for the value of net working capital and net debt, among other items. The final net amount of consideration is subject to certain adjustments within 90 days of the closing date as defined in the share purchase agreement. Upon transaction close, Bunge has agreed to indemnify BP against future losses associated with certain legal claims as defined in the share purchase agreement . During the second quarter of 2024, Bunge received a refundable deposit towards the closing purchase price of $103 million, which is recorded within Other current liabilities on the condensed consolidated balance sheet at September 30, 2024 and as an investing cash inflow within Proceeds from investments in affiliates on the condensed consolidated statement of cash flows for the nine months ended September 30, 2024. Upon the transaction close, the refundable deposit recorded within Other current liabilities on the September 30, 2024 condensed consolidated balance sheet was released. As of September 30, 2024, the carrying value of Bunge's investment in BP Bunge Bioenergia is $369 million. The investment is reported within Investments in affiliates in the Sugar and Bioenergy segment on the condensed consolidated balance sheet. Additionally, $(148) million of Bunge's Accumulated other comprehensive income (loss) as of September 30, 2024 is related to the investment in BP Bunge Bioenergia. Partnership with Repsol - Bunge Iberica SA

TRADE STRUCTURED FINANCE PROGRA

TRADE STRUCTURED FINANCE PROGRAM	9 Months Ended
TRADE STRUCTURED FINANCE PROGRAM	Sep. 30, 2024
Trade Structured Finance Program [Abstract]
TRADE STRUCTURED FINANCE PROGRAM	TRADE STRUCTURED FINANCE PROGRAM The Company engages in various trade structured finance activities to leverage the value of its global trade flows. These activities include programs under which the Company generally obtains U.S. dollar and foreign currency-denominated letters of credit ("LCs") from financial institutions, each based on an underlying commodity trade flow, and time deposits denominated in U.S. dollars and foreign currencies, as well as foreign exchange forward contracts, in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements. As of September 30, 2024, and December 31, 2023, time deposits and LCs of $7,461 million and $6,880 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting , had been met. The net losses and gains related to such activities are included as an adjustment to Cost of goods sold in the accompanying condensed consolidated statements of income. At September 30, 2024, and December 31, 2023, time deposits, including those presented on a net basis, carried weighted-average interest rates of 5.56% and 5.77%, respectively. During the nine months ended September 30, 2024, and 2023, total net proceeds from issuances of LCs were $5,200 million and $4,646 million, respectively. These cash inflows were offset by the related cash outflows resulting from placement of the time deposits and repayment of the LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows. As part of the trade structured finance activities, LCs may be sold to financial institutions on a discounted basis. Bunge does not service derecognized LCs. The terms of the sale may require the Company to continue to make periodic interest payments to financial institutions based on changes in the Secured Overnight Financing Rate ("SOFR") for a period of up to one year. Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current liabilities, including any unrealized gain or loss on changes in SOFR is not significant as of September 30, 2024 or December 31, 2023. The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's condensed consolidated balance sheets as of September 30, 2024, and December 31, 2023 are included in Note 12 - Derivative Instruments And Hedging Activities . The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the three and nine month periods ended September 30, 2024, and 2023.

TRADE ACCOUNTS RECEIVABLE AND T

TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM	9 Months Ended
	Sep. 30, 2024
Transfers and Servicing [Abstract]
TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM	TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM Trade Accounts Receivable Changes to the allowance for expected credit losses related to Trade accounts receivable were as follows: Nine Months Ended September 30, 2024 Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term Long-term (1) Total Allowance as of January 1, 2024 $ 104 $ 32 $ 136 Current period provisions 38 1 39 Recoveries (40) (2) (42) Write-offs charged against the allowance (8) (1) (9) Foreign exchange translation differences (3) (3) (6) Allowance as of September 30, 2024 $ 91 $ 27 $ 118 (1) Long-term portion of the allowance for credit losses is included in Other non-current assets. Nine Months Ended September 30, 2023 Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term Long-term (1) Total Allowance as of January 1, 2023 $ 90 $ 46 $ 136 Current period provisions 55 — 55 Recoveries (44) (2) (46) Write-offs charged against the allowance (2) (12) (14) Foreign exchange translation differences 2 — 2 Allowance as of September 30, 2023 $ 101 $ 32 $ 133 (1) Long-term portion of the allowance for credit losses is included in Other non-current assets. Trade Receivables Securitization Program Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the "Program") with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers (collectively, the "Purchasers"). Koninklijke Bunge B.V., a wholly owned subsidiary of Bunge, acts as master servicer, responsible for servicing and collecting the accounts receivable for the Program. The Program is designed to enhance Bunge’s financial flexibility by providing an additional source of liquidity for its operations. The Program provides for funding of up to $1.5 billion and from time to time with the consent of the administrative agent, Bunge may request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments by an amount not to exceed $1 billion pursuant to an accordion provision. The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate earlier on December 17, 2024, with a feature that permits Bunge to request 364-day extensions. The Program includes sustainability provisions, pursuant to which the applicable margin will be increased or decreased based on Bunge's performance relative to certain sustainability targets, including, but not limited to, science-based targets ("SBTs") that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025. Under the Program's pledge structure, Bunge Securitization B.V. ("BSBV"), a consolidated bankruptcy remote special purpose entity, transfers certain trade receivables to the Purchasers in exchange for a cash payment up to the aggregate size of the Program. Bunge also retains ownership of a population of unsold receivables. BSBV agrees to guaranty the collection of sold receivables and grants a lien to the administrative agent on all unsold receivables. Collections on unsold receivables and guarantee payments are classified as operating activities in Bunge’s condensed consolidated statements of cash flows. (US$ in millions) September 30, December 31, Receivables sold which were derecognized from Bunge's balance sheet $ 1,172 $ 1,230 Receivables pledged to the administrative agent and included in Trade accounts receivable $ 226 $ 343 Bunge's risk of loss following the sale of trade receivables is limited to the assets of BSBV, primarily comprised of unsold receivables pledged to the administrative agent. The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period. Nine Months Ended (US$ in millions) 2024 2023 Gross receivables sold $ 8,809 $ 10,231 Proceeds received in cash related to transfers of receivables $ 8,776 $ 10,186 Cash collections from customers on receivables previously sold $ 8,868 $ 10,231 Discounts related to gross receivables sold included in Selling, general & administrative expenses $ 33 $ 45

INVENTORIES

INVENTORIES	9 Months Ended
INVENTORIES	Sep. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories by segment consist of the following: (US$ in millions) September 30, December 31, Agribusiness $ 6,163 $ 5,830 Refined and Specialty Oils 1,134 1,096 Milling 162 175 Corporate and Other 6 4 Total $ 7,465 $ 7,105 Readily marketable inventories ("RMI") are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. All other inventories are carried at lower of cost or net realizable value. RMI by segment consists of the following: (US$ in millions) September 30, December 31, Agribusiness (1) $ 5,846 $ 5,519 Refined and Specialty Oils 334 302 Milling 15 16 Total $ 6,195 $ 5,837 (1)

OTHER CURRENT ASSETS

OTHER CURRENT ASSETS	9 Months Ended
OTHER CURRENT ASSETS	Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER CURRENT ASSETS	OTHER CURRENT ASSETS Other current assets consist of the following: (US$ in millions) September 30, December 31, Unrealized gains on derivative contracts, at fair value $ 1,025 $ 1,481 Prepaid commodity purchase contracts (1) 393 320 Secured advances to suppliers, net (2) 178 462 Recoverable taxes, net 302 378 Margin deposits 773 618 Marketable securities and other short-term investments (3) 178 105 Income taxes receivable 86 54 Prepaid expenses 194 346 Restricted cash 53 21 Other 336 266 Total $ 3,518 $ 4,051 (1) Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14- Related Party Transactions . (2) Bunge provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14- Related Party Transactions. The Company does not bear any of the costs or operational risks associated with growing the related crops. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to suppliers are reported net of allowances of $7 million and $8 million at September 30, 2024, and December 31, 2023, respectively. (-) Interest earned on secured advances to suppliers of $4 million and $6 million for the three months ended September 30, 2024, and 2023, respectively, and $20 million and $17 million for the nine months ended September 30, 2024, and 2023, respectively, is included in Net sales in the condensed consolidated statements of income. (3) Marketable securities and other short-term investments - Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the Company's condensed consolidated balance sheets as marketable securities and other short-term investments. (US$ in millions) September 30, December 31, Foreign government securities $ 60 $ 39 Certificates of deposit/time deposits 19 — Equity securities 21 28 Other 78 38 Total $ 178 $ 105 As of September 30, 2024, and December 31, 2023, $102 million and $67 million, respectively, of marketable securities and other short-term investments were recorded at fair value. All other investments were recorded at cost, and due to the short-term nature of these investments, their carrying values approximate fair values. For the three months ended September 30, 2024, and 2023, unrealized gains/(losses) of $7 million and $(4) million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2024, and 2023. For the nine months ended September 30, 2024, and 2023, unrealized gains/(losses) of $(1) million and $(10) million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2024, and 2023.

OTHER NON-CURRENT ASSETS

OTHER NON-CURRENT ASSETS	9 Months Ended
OTHER NON-CURRENT ASSETS	Sep. 30, 2024
Other Assets, Noncurrent [Abstract]
OTHER NON-CURRENT ASSETS	OTHER NON-CURRENT ASSETS Other non-current assets consist of the following: (US$ in millions) September 30, December 31, Recoverable taxes, net (1) $ 20 $ 25 Judicial deposits (1) 100 120 Other long-term receivables, net (2) 16 16 Income taxes receivable (1) 135 136 Long-term investments (3) 174 142 Affiliate loans receivable 8 8 Long-term receivables from farmers in Brazil, net (1) 28 43 Unrealized gains on derivative contracts, at fair value 1 1 Other 113 124 Total $ 595 $ 615 (1) A significant portion of these non-current assets arise from the Company’s Brazilian operations and their realization could take several years. (2) Net of allowances as described in Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program . (3) As of September 30, 2024, and December 31, 2023, $13 million and $12 million, respectively, of long-term investments are recorded at fair value. Recoverable taxes, net - Recoverable taxes include value-added taxes paid upon the acquisition of property, plant and equipment, raw materials and taxable services, and other transactional taxes which can be recovered in cash or as compensation against income taxes, or other taxes Bunge may owe, primarily in Brazil and Europe. Recoverable taxes are reported net of allow ances of $12 million and $13 million at September 30, 2024, and December 31, 2023, respectively. Judicial deposits - Judicial deposits are funds the Company has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending resolution and bear interest at the Selic rate, which is the benchmark rate of the Brazilian central bank. Income taxes receivable - Income taxes receivable include overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be used for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate. Long-term investments - Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures. Affiliate loans receivable - Affiliate loans receivable are primarily interest-bearing receivables from unconsolidated affiliates with remaining maturities of greater than one year. Long-term receivables from farmers in Brazil, net - The Company provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest of the then-current year’s crop, and through credit sales of fertilizer to farmers. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14- Related Party Transactions . Certain such long-term receivables from farmers are originally recorded in Other current assets as prepaid commodity purchase contracts or secured advances to suppliers (see Note 6 - Other Current Assets ) or Other non-current assets according to their maturity. Advances initially recorded in Other current assets are reclassified to Other non-current assets if collection issues arise and amounts become past due with resolution of such matters expected to take more than one year. The average recorded investment in long-term receivables from farmers in Brazil for the nine months ended September 30, 2024, and the year ended December 31, 2023, was $72 million and $88 million, respectively. The table below summarizes the Company’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts. September 30, 2024 December 31, 2023 (US$ in millions) Recorded Allowance Recorded Allowance For which an allowance has been provided: Legal collection process (1) $ 28 $ 28 $ 30 $ 30 Renegotiated amounts — — 2 1 For which no allowance has been provided: Legal collection process (1) 11 — 19 — Renegotiated amounts (2) 4 — 5 — Other long-term receivables (3) 13 — 18 — Total $ 56 $ 28 $ 74 $ 31 (1) All amounts in legal collection processes are considered past due upon initiation of legal action. (2) These renegotiated amounts are current on repayment terms. (3) New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date. Such advances are reclassified from Other non-current assets to Other current assets in later periods depending on the expected date of their realization. The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil. Nine Months Ended (US$ in millions) 2024 2023 Allowance as of January 1 $ 31 $ 36 Bad debt provisions 1 1 Recoveries — (3) Write-offs — (5) Transfers — — Foreign exchange translation (4) 2 Allowance as of September 30 $ 28 $ 31

INVESTMENTS IN AFFILIATES AND V

INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES	9 Months Ended
INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES	Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES	INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES Investment in Affiliates BP Bunge Bioenergia On June 19, 2024, Bunge entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. On October 1, 2024, the transaction closed in accordance with the terms of the share purchase agreement. See Note 2 - Acquisitions and Dispositions for further information . Terminal XXXIX De Santos S.A. (“T-39”) On May 29, 2024, Bunge entered into a share purchase agreement to indirectly acquire a 25% interest of T-39. The acquisition price for Bunge's 25% interest is Brazilian reais 300 million (approximately $54 million). T-39 operations primarily consist of a port facility located in the Port of Santos, Brazil. The transaction is expected to close in early 2025, subject to customary closing conditions. Impairment of Equity Method Investment During the nine months ended September 30, 2024, the Company recorded an impairment of $19 million associated with a minority investment in North America. The impairment was determined through management's review of impairment indicators and consideration of the other-than temporary nature of such items. Impairment charges were recorded to Income (loss) from affiliates within the Agribusiness segment. Consolidated Variable Interest Entities On September 19, 2023, Bunge entered into a fixed-priced call option agreement ("Option") to acquire the shares of Terminal de Granéis de Santa Catarina ("TGSC") with primary assets consisting of a grain port terminal currently under construction in South America strategically located near an existing Bunge facility. The agreement requires Bunge to make future installment payments for the Option which will be utilized, in part, to fund terminal construction. TGSC is a VIE as a result of having insufficient equity at risk. Bunge is the primary beneficiary due to a de facto agent relationship with the equity owner of TGSC and has consolidated the entity. As all of TGSC’s equity is held by a third-party, Bunge reflects all TGSC earnings and equity as attributable to noncontrolling interests in the condensed consolidated statements of income and condensed consolidated balance sheets, respectively. Further, Bunge Chevron Ag Renewables LLC ("BCAR") is a VIE in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of BCAR as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by BCAR, among other factors. The following table presents the values of the assets and liabilities associated with the above listed VIEs in which Bunge is considered the primary beneficiary to the extent included in Bunge’s condensed consolidated balance sheets as of September 30, 2024, and December 31, 2023. All amounts exclude intercompany balances, which have been eliminated upon consolidation. For all other VIEs in which Bunge is considered the primary beneficiary, the entities meet the definition of a business, and the VIE's assets can be used other than for the settlement of the VIE’s obligations. As such, these VIEs have been excluded from the below table. (US$ in millions) September 30, December 31, Current assets: Cash and cash equivalents $ 567 $ 606 Trade accounts receivable 4 1 Inventories 47 76 Other current assets 31 146 Total current assets 649 829 Property, plant and equipment, net 368 196 Other intangible assets, net 80 91 Total assets $ 1,097 $ 1,116 Current liabilities: Trade accounts payable and accrued liabilities $ 57 $ 70 Other current liabilities 33 143 Total current liabilities 90 213 Long-term debt 47 44 Other non-current liabilities 9 5 Total liabilities $ 146 $ 262 Non-Consolidated Variable Interest Entities In 2024, Bunge's maximum exposure to loss associated with VIEs for which Bunge has determined it is not the primary beneficiary increased approximately $96 million as a result of certain future commitments related to an unconsolidated VIE. For additional information on VIEs for which Bunge has determined it is not the primary beneficiary, along with the Company's related maximum exposure to losses associated with such investments, please refer to Note 11 - Investments in Affiliates and Variable Interest Entities

INCOME TAXES

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-recurring tax adjustments in the interim period in which they occur. In addition, results from jurisdictions projecting a loss for the year where no tax benefit can be recognized are treated discretely in the interim period in which they occur. The effective tax rate is highly dependent on the geographic distribution of the Company’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate, including the realizability of deferred tax assets, and adjusts estimates accordingly. Volatility in earnings within a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted. Income tax expense for the three and nine months ended September 30, 2024, was $89 million and $236 million, respectively. Income tax expense for the three and nine months ended September 30, 2023, was $114 million and $495 million, respectively. The effective tax rate for the three and nine months ended September 30, 2024, was higher than the U.S. statutory rate of 21% primarily due to jurisdictional mix of earnings and unfavorable adjustments related to foreign currency fluctuations in South America. The effective tax rate for the three and nine months ended September 30, 2023, was higher than the U.S. statutory rate of 21% primarily due to jurisdictional mix of earnings. As a global enterprise, the Company files income tax returns that are subject to periodic examination and challenge by federal, state, and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or litigation, may take several years to finalize. The Company is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.

OTHER CURRENT LIABILITIES

OTHER CURRENT LIABILITIES	9 Months Ended
OTHER CURRENT LIABILITIES	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
OTHER CURRENT LIABILITIES	OTHER CURRENT LIABILITIES Other current liabilities consist of the following: (US$ in millions) September 30, December 31, Unrealized losses on derivative contracts, at fair value $ 1,100 $ 1,038 Accrued liabilities 784 865 Advances on sales (1) 279 463 Dividends payable (2) 190 96 Income tax payable 105 238 Disposition deposit (3) 103 — Other 213 213 Total $ 2,774 $ 2,913 (1) The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less. (2) See Note 17 - Equity . (3) On June 19, 2024, Bunge entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. In the second quarter of 2024, Bunge received a refundable deposit towards the closing purchase price of $103 million. On October 1, 2024, the transaction closed in accordance with the terms of the share purchase agreement . See Note 2 - Acquisitions and Dispositions for further information.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
FAIR VALUE MEASUREMENTS	Sep. 30, 2024
Financial Instruments And Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Bunge's various financial instruments include certain components of working capital such as Trade accounts receivable and Trade accounts payable. Additionally, Bunge uses short- and long-term debt to fund operating requirements. Trade accounts receivable, Trade accounts payable, and Short-term debt are generally stated at their carrying value, which is a reasonable estimate of fair value. See Note 3 - Trade Structured Finance Program for trade structured finance program, Note 7 - Other Non-Current Assets for long-term receivables from farmers in Brazil, net and other long-term investments, and Note 13 - Debt for short- and long-term debt. Bunge's financial instruments also include derivative instruments and marketable securities, which are stated at fair value. The fair value standard describes three levels within its hierarchy that may be used to measure fair value. Level Description Financial Instrument (Assets / Liabilities) Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities. Exchange traded derivative contracts. Marketable securities in active markets. Level 2 Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Exchange traded derivative contracts (less liquid markets). Level 3 Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities. Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques. In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels. For a further definition of fair value and the associated fair value levels, refer to Note 15 - Fair Value Measurements, included in the Company's 2023 Annual Report on Form 10-K. The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis. Fair Value Measurements at Reporting Date September 30, 2024 December 31, 2023 (US$ in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 150 $ 20 $ — $ 170 $ 315 $ 149 $ — $ 464 Readily marketable inventories (Note 5) — 5,067 1,128 6,195 — 5,175 662 5,837 Trade accounts receivable (1) — 1 — 1 — 1 — 1 Unrealized gain on derivative contracts (2) : Interest rate — 13 — 13 — 12 — 12 Foreign exchange — 348 — 348 — 253 — 253 Commodities 60 449 74 583 198 737 88 1,023 Freight 45 — — 45 80 — — 80 Energy 35 — — 35 114 — — 114 Credit — 2 — 2 — — — — Other (3) 82 33 — 115 40 39 — 79 Total assets $ 372 $ 5,933 $ 1,202 $ 7,507 $ 747 $ 6,366 $ 750 $ 7,863 Liabilities: Trade accounts payable (1) $ — $ 394 $ 175 $ 569 $ — $ 591 $ 232 $ 823 Unrealized loss on derivative contracts (4) : Interest rate — 174 — 174 1 273 — 274 Foreign exchange — 276 — 276 — 223 — 223 Commodities 67 551 57 675 166 417 17 600 Freight 74 — — 74 68 — — 68 Energy 45 1 — 46 132 1 — 133 Credit — 2 — 2 — — — — Total liabilities $ 186 $ 1,398 $ 232 $ 1,816 $ 367 $ 1,505 $ 249 $ 2,121 (1) These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business. (2) Unrealized gains on derivative contracts are generally included in Other current assets. There were $1 million included in Other non-current assets at September 30, 2024, and December 31, 2023, respectively. (3) Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets. (4) Unrealized losses on derivative contracts are generally included in Other current liabilities. There were $147 million and $260 million included in Other non-current liabilities at September 30, 2024, and December 31, 2023, respectively. Cash equivalents —Cash equivalents primarily includes money market funds and commercial paper investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Cash equivalents with liquid prices are valued using prices from publicly available sources and classified as Level 1. Cash equivalents with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2. Readily marketable inventories —RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where the Company's inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3. If the Company used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Derivatives —The majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. The majority of the Company’s exchange traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. The Company's forward commodity purchase and sales contracts are classified as derivatives along with other OTC derivative instruments, primarily relating to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3 as described below. The Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations, or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2. OTC derivative contracts include swaps, options, and structured transactions that are generally fair valued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices, and indices, to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market. Marketable securities and investments —Comprise foreign government securities, corporate debt securities, deposits, equity securities, and other investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Marketable securities and investments with liquid prices are valued using prices from publicly available sources and classified as Level 1. Marketable securities and investments with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2 or Level 3 as described below. Level 3 Measurements The following relates to assets and liabilities measured at fair value on a recurring basis using Level 3 measurements. An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable. Level 3 Measurements —Transfers in and/or out of Level 3 represent existing assets or liabilities that were either previously categorized as a higher level for which the inputs to the model became unobservable or assets and liabilities that were previously classified as Level 3 for which the lowest significant input became observable during the period. Bunge's policy regarding the timing of transfers between levels is to record the transfers at the end of the reporting period. Level 3 Readily marketable inventories and Trade accounts payable —The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sales contracts, and Trade accounts payable, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, the Company uses proprietary information such as purchase and sales contracts and contracted prices to value freight, premiums and discounts in its contracts. Movements in the prices of these unobservable inputs alone would not be expected to have a material effect on the Company's financial statements as these contracts do not typically exceed one future crop cycle. Level 3 Derivatives —Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements. These inputs include commodity prices, price volatility, interest rates, volumes, and locations. Level 3 Others —Primarily relates to marketable securities and investments valued using third-party quotes or pricing models with inputs based on similar securities adjusted to reflect management’s best estimate of the specific characteristics of the securities held by the Company. Such inputs represent a significant component of the fair value of the securities held by the Company, resulting in the securities being classified as Level 3. The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2024, and 2023. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant. Three Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, July 1, 2024 $ 1,262 $ 13 $ (377) $ 898 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 153 (8) 2 147 Purchases 215 — (10) 205 Sales (610) — — (610) Settlements — — 191 191 Transfers into Level 3 396 16 (68) 344 Transfers out of Level 3 (311) (4) 95 (220) Translation adjustment 23 — (8) 15 Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Three Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, July 1, 2023 $ 1,384 $ 9 $ (437) $ 11 $ 967 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 300 39 3 — 342 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — 1 1 Purchases 554 — (21) — 533 Sales (699) — — — (699) Settlements — — 158 — 158 Transfers into Level 3 450 22 (32) — 440 Transfers out of Level 3 (854) (31) 2 — (883) Translation adjustment (41) — 16 — (25) Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $207 million, $24 million and $3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $1 million mark-to-market losses related to securities still held at September 30, 2023. Nine Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, January 1, 2024 $ 662 $ 71 $ (232) $ 501 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 580 (68) 14 526 Purchases 1,594 — (438) 1,156 Sales (1,760) — — (1,760) Settlements — — 499 499 Transfers into Level 3 1,108 20 (233) 895 Transfers out of Level 3 (986) (6) 155 (837) Translation adjustment (70) — 60 (10) Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $488 million, $(50) million and $14 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2024. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Nine Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, January 1, 2023 $ 412 $ 51 $ (130) $ 27 $ 360 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 665 (32) 21 — 654 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — (1) (1) Purchases 2,767 — (450) — 2,317 Sales (2,215) — — (14) (2,229) Settlements — — 329 — 329 Transfers into Level 3 1,658 51 (113) — 1,596 Transfers out of Level 3 (2,216) (31) 44 — (2,203) Translation adjustment 23 — (12) — 11 Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $648 million, $(20) million and $22 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $15 million in mark-to-market losses related to securities still held at September 30, 2023.

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency rate, and commodity risk. Some of those hedges the Company enters into qualify for hedge accounting ("Hedge Accounting Derivatives") and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting ("Economic Hedge Derivatives"). As these derivatives impact the financial statements in different ways, they are discussed separately below. Hedge Accounting Derivatives - The Company uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, foreign currency, and commodity risks. In executing these hedge strategies, the Company primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative. Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of a change in the fair value of the derivative will be substantially offset by the earnings effect of the change in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. For cross currency swaps, the changes in currency risk on the derivative are recognized in Foreign exchange gains (losses) – net, and the changes in interest rate risk are recognized in Interest expense. Changes in basis risk are held in Accumulated other comprehensive income (loss) until realized through the coupon. Cash flow hedges of currency risk - The Company manages currency risk on certain forecasted purchases, sales, and selling, general and administrative expenses with currency forwards. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the currency forward is reclassified to Net sales, Cost of goods sold, or Selling, general and administrative expenses. These hedges mature at various times through December 2025. Of the amount currently in Accumulated other comprehensive income (loss), $1 million of deferred losses are expected to be reclassified to earnings in the next twelve months. Net investment hedges - The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings by way of either sale or substantial liquidation of the foreign subsidiary. The table below provides information about the balance sheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis. (US$ in millions) September 30, December 31, 2023 Unit of Hedging instrument type: Fair value hedges of interest rate risk Interest rate swap - notional amount $ 2,700 $ 2,900 $ Notional Cumulative adjustment to long-term debt from active application of hedge accounting $ (165) $ (260) $ Notional Carrying value of hedged debt $ 2,525 $ 2,625 $ Notional Cash flow hedges of currency risk Foreign currency forward - notional amount $ 7 $ 54 $ Notional Foreign currency option - notional amount $ 102 $ 99 $ Notional Net investment hedges Foreign currency forward - notional amount $ 1,194 $ 1,112 $ Notional Economic Hedge Derivatives - In addition to using derivatives in qualifying hedge relationships, the Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations. Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances. The impact of changes in fair value of these instruments is primarily presented in Interest expense. Currency derivatives are used to hedge the balance sheet and commercial exposures that arise from the Company's global operations. The impact of changes in fair value of these instruments is presented in Cost of goods sold when hedging commercial exposures and Foreign exchange (losses) gains – net when hedging monetary exposures. Agricultural commodity derivatives are used primarily to manage exposures related to the Company's inventory and forward purchase and sales contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The Company uses derivative instruments referred to as forward freight agreements ("FFAs") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The Company uses energy derivative instruments to manage its exposure to volatility in energy costs. Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The table below summarizes the volume of economic derivatives as of September 30, 2024, and December 31, 2023. For those contracts traded bilaterally through the over-the-counter markets (e.g., forwards, forward rate agreements ("FRA"), and swaps), the gross position is provided. For exchange traded (e.g., futures, FFAs, and options) and cleared positions (e.g., energy swaps), the net position is provided. September 30, December 31, 2024 2023 Unit of (US$ in millions) Long (Short) Long (Short) Interest rate Swaps $ 295 $ (1,422) $ 935 $ (1,465) $ Notional Futures $ — $ (299) $ — $ (612) $ Notional Forwards $ — $ — $ 416 $ (416) $ Notional Options $ — $ — $ — $ (3) $ Notional Currency Forwards $ 10,724 $ (11,697) $ 8,808 $ (10,356) $ Notional Swaps $ 2,759 $ (1,646) $ 1,357 $ (324) $ Notional Futures $ — $ (4) $ — $ (2) $ Notional Options $ 7 $ (33) $ 5 $ (5) Delta Agricultural commodities Forwards 22,752,408 (31,474,803) 25,588,125 (34,163,143) Metric Tons Futures — (7,590,458) — (1,224,688) Metric Tons Options 299,044 (580) 29,420 (615,937) Metric Tons Ocean freight FFA — (9,538) — (4,965) Hire Days Natural gas Forwards 500 (100) 300 — MMBtus Swaps 1,260,900 — 778,436 — MMBtus Futures 10,231,918 — 12,715,588 — MMBtus Options 507,727 — — (2,923,438) MMBtus Electricity Futures 67,321 — — (281,511) Mwh Energy - other Swaps 267,488 — 202,716 — Metric Tons Options — — 40,920 — Metric Tons Energy - CO2 Futures 245,000 — 675,000 — Metric Tons Options 400,000 — 400,000 — Metric Tons Other Swaps and futures $ 90 $ (90) $ 100 $ (106) $ Notional The Effect of Derivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2024, and 2023. Gain (Loss) Recognized in Three Months Ended September 30, (US$ in millions) 2024 2023 Income statement classification Type of derivative Net sales Hedge accounting Foreign currency $ (1) $ 2 Cost of goods sold Hedge accounting Foreign currency $ — $ 1 Economic hedges Foreign currency 39 (41) Commodities (202) 30 Other (1) (37) 79 Total Cost of goods sold $ (200) $ 69 Interest expense Hedge accounting Interest rate $ (31) $ (35) Foreign exchange (losses) gains – net Hedge accounting Foreign currency $ — $ (5) Economic hedges Foreign currency (7) 10 Total Foreign exchange (losses) gains – net $ (7) $ 5 Other income (expense) Economic hedges Interest rate $ — $ (1) Other comprehensive income (loss) Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ — $ 1 Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ (18) $ 10 Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period $ (39) $ 20 Amounts released from Accumulated other comprehensive income (loss) during the period Cash flow hedge of foreign currency risk - loss/(gain) $ (1) $ (1) (1) Other includes results from freight, energy, and other derivatives. Gain (Loss) Recognized in Nine months ended September 30, (US$ in millions) 2024 2023 Income statement classification Type of derivative Net sales Hedge accounting Foreign currency $ (1) $ 6 Cost of goods sold Hedge accounting Foreign currency $ — $ 1 Economic hedges Foreign currency (160) 367 Commodities (228) 394 Other (1) (91) 86 Total Cost of goods sold $ (479) $ 848 Selling, general & administrative expenses Hedge Accounting Foreign exchange $ — $ 1 Interest expense Hedge accounting Interest rate $ (92) $ (103) Economic hedges Interest rate — 6 Total Interest expense $ (92) $ (97) Foreign exchange (losses) gains Hedge accounting Foreign currency $ — $ (26) Economic hedges Foreign currency (5) 4 Total Foreign exchange (losses) gains - net $ (5) $ (22) Other income (expense) Economic hedges Interest rate $ — $ 1 Other comprehensive income (loss) Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ — $ 1 Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ 4 $ (21) Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period $ 64 $ (41) Amounts released from Accumulated other comprehensive income (loss) during the period Cash flow hedge of foreign currency risk - loss/(gain) $ (2) $ (1) (1) Other includes results from freight, energy, and other derivatives

DEBT

DEBT	9 Months Ended
DEBT	Sep. 30, 2024
Debt Disclosure [Abstract]
DEBT	DEBT The following table summarizes Bunge's short and long-term debt: (US$ in millions) September 30, December 31, Short-term debt and Current portion of long-term debt: Revolving credit facilities $ — $ — Commercial paper (1) — — Other short-term debt 755 797 Total Short-term debt 755 797 Current portion of long-term debt 663 5 Total Short-term debt and Current portion of long-term debt (2) 1,418 802 Long-term debt: (3) Term loan due 2025 - SOFR plus 0.90% (4) — 750 Term loan due 2027 - SOFR plus 1.125% 250 250 Term loan due 2028 - SOFR plus 1.325% 250 249 1.63% Senior Notes due 2025 599 598 3.25% Senior Notes due 2026 699 698 3.75% Senior Notes due 2027 598 597 4.10% Senior Notes due 2028 (5) 397 — 4.20% Senior Notes due 2029 (5) 792 — 2.75% Senior Notes due 2031 992 991 4.65% Senior Notes due 2034 (5) 790 — Cumulative adjustment to long-term debt from application of hedge accounting (189) (260) Other long-term debt 262 212 Subtotal (6) 5,440 4,085 Less: Current portion of long-term debt (663) (5) Total Long-term debt (7) 4,777 4,080 Total debt $ 6,195 $ 4,882 (1) On April 12, 2024, Bunge increased the aggregate size of its existing commercial paper program by $1 billion to an aggregate of $2 billion. (2) Includes secured debt of $207 million and $200 million at September 30, 2024, and December 31, 2023, respectively. (3) Variable interest rates are as of September 30, 2024. (4) On September 30, 2024, Bunge prepaid and terminated its 3-year term loan agreement due in 2025. (5) See Viterra Acquisition Financing section within Note 13 - Debt below for further details . (6) The fair value (Level 2) of long-term debt, including current portion, is $5,456 million and $4,125 million at September 30, 2024, and December 31, 2023, respectively. The fair value of Bunge's long-term debt is calculated based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. (7) Includes secured debt of $129 million and $100 million at September 30, 2024, and December 31, 2023, respectively. Updates to Revolving Credit Facilities On March 1, 2024, Bunge entered into an unsecured $3.2 billion 5-year revolving credit agreement (the "$3.2 Billion Revolving Credit Agreement") with a group of lenders, maturing on March 1, 2029. Bunge may from time to time request one or more of the existing or new lenders to increase the total participations by an aggregate amount up to $1.5 billion, pursuant to an accordion provision. Current commitments in the aggregate amount of $1.95 billion are available to be drawn. Incremental commitments in the aggregate amount of $1.25 billion are available to be drawn on and after the date Bunge completes its acquisition of Viterra, subject to the satisfaction of certain conditions. Therefore, upon completion of the acquisition of Viterra, the total committed capacity will be an aggregate of $3.2 billion. The $3.2 Billion Revolving Credit Agreement replaced an existing $1.95 billion 5-year revolving credit agreement which was terminated on March 1, 2024. On March 1, 2024, Bunge exercised the accordion provision set forth in its existing unsecured $1.75 billion 3-year revolving facility agreement (as amended, the "$3.5 Billion Revolving Facility Agreement") in an aggregate amount of additional committed capacity of $1.75 billion which is available to be drawn on and after the date Bunge completes its acquisition of Viterra. Upon completion of the acquisition of Viterra, the total committed capacity will be an aggregate of $3.5 billion. The funding cost is also subject to certain premiums or discounts tied to certain sustainability criteria, including, but not limited to, SBTs that define Bunge’s climate goals within its operations and a commitment to a deforestation-free supply chain in 2025. The $3.5 Billion Revolving Credit Agreement matures on October 6, 2026. Further, on April 12, 2024, Bunge amended and restated its existing $1.1 billion 364-day revolving credit agreement (the “$1.1 Billion 364-day Revolving Credit Agreement”) with a group of lenders, to extend the maturity date from June 19, 2024 to April 11, 2025. Bunge may from time to time request one or more of the existing or new lenders to increase the total participations under the $1.1 Billion 364-day Revolving Credit Agreement by an aggregate amount up to $250 million, pursuant to an accordion provision. Viterra Acquisition Financing As described in Note 2 - Acquisitions and Dispositions , Bunge secured a total of $8.0 billion in Acquisition Financing in the form of a $7.7 billion financing commitment from a consortium of lenders, arranged by Sumitomo Mitsui Banking Corporation and a $300 million 5-year delayed draw term loan from CoBank and the U.S. farm credit system executed July 7, 2023 that may be drawn upon the closing of the Acquisition. As a result of the Senior Notes issuance discussed further below, the $7.7 billion financing commitment has been reduced to $5.7 billion. The $5.7 billion financing commitment is in the form of a three tranche term loan maturing 364-days, 2-years and 3-years from closing of the Acquisition. Senior Notes - On September 17, 2024, Bunge completed the sale and issuance of (i) $400 million aggregate principal amount of 4.100% senior notes due 2028, (ii) $800 million aggregate principal amount of 4.200% senior notes due 2029, and (iii) $800 million aggregate principal amount of 4.650% senior notes due 2034. Collectively, the three tranches of Senior Notes total an aggregate principal amount of $2.0 billion. The Senior Notes are fully and unconditionally guaranteed by Bunge. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No. 333-282003) filed by the Company and its 100% owned finance subsidiary, BLFC, with the U.S. Securities and Exchange Commission. The net proceeds of the offering were approximately $1.98 billion after deducting underwriting commissions, the original issue discount, and offering fees and expenses payable by Bunge. The net proceeds from the offering are expected to be used to fund a portion of the cash consideration for Bunge's Acquisition of Viterra and to repay a portion of certain Viterra debt to be assumed in connection with the Acquisition, including, in each case, related fees and expenses, and, with any remaining amounts, for general corporate purposes. The Senior Notes are subject to a special mandatory redemption at a price equal to 101% of the aggregate principal amount, plus accrued and unpaid interest, under certain circumstances, including if the Acquisition of Viterra is not consummated or the Acquisition is not consummated by an agreed upon date per the terms of the Business Combination Agreement. Exchange Offers and Consent Solicitations of Viterra Notes - On September 9, 2024, Bunge announced that, in connection with its pending Acquisition of Viterra, Bunge's 's wholly-owned subsidiary, BLFC, commenced US Exchange Offers to exchange all outstanding notes of certain series (the "Existing USD Viterra Notes") issued by VFBV and guaranteed by Viterra and Viterra B.V., for up to $1.95 billion aggregate principal amount of new notes issued by BLFC and guaranteed by Bunge. Concurrently with the US Exchange Offers, BLFC successfully solicited consents, on behalf of VFBV, and VFBV amended the respective indentures governing the Existing USD Viterra Notes on September 23, 2024 to, among other things, eliminate certain of the covenants, restrictive provisions and events of default, and modify or amend certain other provisions, including unconditionally releasing and discharging the guarantees by each of Viterra and Viterra B.V. In addition, in the third quarter of 2024, Viterra commenced the European Consent Solicitation to amend the indenture governing VFBV's outstanding 500 million Euro aggregate principal amount of 0.375% senior unsecured notes due 2025 and outstanding 700 million Euro aggregate principal amount of 1.000% senior unsecured notes due 2028 (collectively, the "Existing Euro Viterra Notes") to, among other things, substitute the issuer and guarantors of such notes with BFE, a wholly owned finance subsidiary of Bunge, as issuer, and Bunge as guarantor. The resolutions to effect such amendments have been passed by the requisite number of noteholders.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties. Such related party purchases comprised approximately 9% or less of total Cost of goods sold for the three and nine months ended September 30, 2024, and 2023. Bunge also sells agricultural commodity products to certain of its unconsolidated investees and other related parties. Such related party sales comprised approximately 2% or less of total Net sales for the three and nine months ended September 30, 2024, and 2023. In addition, Bunge receives services from and provides services to its unconsolidated investees and other related parties, including tolling, port handling, administrative support, and other services. For the three and nine months ended September 30, 2024, and 2023, such services were not material to the Company's consolidated results. At September 30, 2024, and December 31, 2023, receivables related to the above related party transactions comprised approximately 3% or less of total Trade accounts receivable. At September 30, 2024, and December 31, 2023, payables related to the above related party transactions comprised approximately 3% or less of total Trade accounts payable. Further, as referenced in Note 6 - Other Current Assets and Note 7 - Other Non-Current Assets , Bunge provides certain advance payments for future delivery of specified quantities of agricultural commodities and advances to its unconsolidated investees. At September 30, 2024, and December 31, 2023 , advances to unconsolidated investees comprised approximat ely 4% or less of total Other current assets and 8% or le ss of total Other non-current assets.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Bunge is party to claims and lawsuits, primarily non-income tax and labor claims in South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. Bunge records liabilities related to legal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations, or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period in which the uncertainties are resolved should the liability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Information regarding the claims appears in Bunge’s Report on Form 10-K for the year ended December 31, 2023. Included in Other non-current liabilities as of September 30, 2024, and December 31, 2023, are the following amounts related to these matters: (US$ in millions) September 30, December 31, Non-income tax claims $ 21 $ 19 Labor claims 48 66 Civil and other claims 106 114 Total $ 175 $ 199 Brazil Indirect Taxes - non-income tax claims - These tax claims relate to claims against Bunge’s Brazilian subsidiaries, primarily value-added tax claims (ICMS, ISS, IPI and PIS/COFINS) plus applicable interest and penalties on the outstanding amounts. As of September 30, 2024, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS/COFINS tax returns and have issued outstanding claims. The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable. The outstanding claims comprise the following: (US$ in millions) Years Examined September 30, 2024 December 31, 2023 ICMS 1990 to Present $ 157 $ 212 PIS/COFINS 2002 to Present $ 422 $ 438 Labor claims — The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits. Civil and other claims — The civil and other claims relate to various disputes with third parties, including suppliers and customers. Guarantees — Bunge has issued or was a party to the following guarantees at September 30, 2024: (US$ in millions) Recorded Liability Maximum Unconsolidated affiliates guarantee (1) $ 16 $ 150 Residual value guarantee (2) — 384 Russia disposition indemnity (3) 9 235 Other guarantees — 12 Total $ 25 $ 781 (1) Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, certain Bunge subsidiaries have guaranteed the obligations of certain of their unconsolidated affiliates and in connection therewith have secured their guarantee obligation s through a pledge to the financial institutions of certain of their unconsolidated affiliates' shares plus loans receivable from the unconsolidated affiliates in the event that the guaranteed obligations are enforced. Based on amounts drawn under such guaranteed debt facilities at September 30, 2024, Bunge's potential liability was $124 million, and it has recorded $16 million of obligations and potential losses related to these guarantees within Other current liabilities and Other non-current liabilities. (2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2024 through 2029. At September 30, 2024, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations. (3) On February 3, 2023, Bunge agreed to indemnify the buyer of its Russian operations against certain existing legal claims involving Bunge's Russian subsidiary. The indemnity expires on February 2, 2030. As of September 30, 2024, Bunge recorded a $9 million obligation related to this indemnity within Other non-current liabilities. Bunge Global SA has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. ("BNA"), an indirect wholly-owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.

OTHER NON-CURRENT LIABILITIES

OTHER NON-CURRENT LIABILITIES	9 Months Ended
OTHER NON-CURRENT LIABILITIES	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
OTHER NON-CURRENT LIABILITIES	OTHER NON-CURRENT LIABILITIES Other non-current liabilities consist of the following: (US$ in millions) September 30, December 31, Labor, legal, and other provisions $ 194 $ 218 Pension and post-retirement obligations (1) 153 170 Uncertain income tax positions (2) 75 68 Unrealized losses on derivative contracts, at fair value (3) 147 260 Other 101 108 Total $ 670 $ 824 (1) On October 2, 2024, the Company, as plan sponsor for one of Bunge's defined benefit U.S. pension plans, utilized approximately $377 million of plan assets to purchase an equally valued buy-in contract from a third-party insurer. On October 22, 2024, the Company notified plan participants in the same defined benefit U.S. pension plan of its intent to offer a lump sum buyout to eligible participants and terminate the plan, which is expected to be completed in the second half of fiscal year 2025. The October 2024 actions had no impact on the condensed consolidated financial statements as of September 30, 2024. (2) See Note 9 - Income Taxes. (3) See Note 11- Fair Value Measurements .

EQUITY

EQUITY	9 Months Ended
EQUITY	Sep. 30, 2024
Stockholders' Equity Note [Abstract]
EQUITY	EQUITY Share repurchase program — As noted in Note 2 - Acquisitions and Dispositions , on June 12, 2023, Bunge Limited's Board of Directors approved the expansion of an existing $500 million program for the repurchase of Bunge’s issued and outstanding shares. At the time, approximately $300 million of capacity for the repurchase of Bunge Limited shares remained available under the existing program and Bunge Limited's Board of Directors approved the expansion of the program by an additional $1.7 billion, for an aggregate unutilized capacity of $2.0 billion at June 12, 2023. The program continues to have an indefinite term. During the three months ended September 30, 2024, Bunge repurchased 2,063,956 shares for $200 million; and during the nine months ended September 30, 2024, Bunge repurchased 6,440,930 shares for $600 million. As of September 30, 2024, 13,957,906 shares were repurchased for $1.4 billion and $800 million remained outstanding for repurchases under the program. Dividends on registered shares — We paid cash dividends to shareholders as follows: Three Months Ended September 30, Nine Months Ended 2024 2023 2024 2023 Dividends paid per share $ 0.68 $ 0.6625 $ 2.0225 $ 1.9125 Dividend distributions occurring after the Redomestication are at the discretion of the Board of Directors and the approval of shareholders at a general meeting in accordance with Swiss law. On May 15, 2024, shareholders of Bunge Global SA approved a cash dividend distribution in the amount of $2.72 per share, payable in four equal quarterly installments of $0.68 per share beginning in the second quarter of fiscal year 2024 and ending in the first quarter of fiscal year 2025. Upon approval of a dividend, the obligation is reflected in Other current liabilities with a corresponding reduction in Retained earnings in the condensed consolidated balance sheet. At September 30, 2024, and December 31, 2023, the unpaid portion of the dividends accrued in Other current liabilities on the condensed consolidated balance sheets totaled $190 million and $96 million, respectively, see Note 10- Other Current Liabilities . Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of Accumulated other comprehensive income (loss) attributable to Bunge: (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, July 1, 2024 $ (6,005) $ (321) $ (120) $ (6,446) Other comprehensive income (loss) before reclassifications 150 (57) — 93 Amount reclassified from accumulated other comprehensive income (loss) — (1) — (1) Balance, September 30, 2024 $ (5,855) $ (379) $ (120) $ (6,354) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, July 1, 2023 $ (5,554) $ (435) $ (102) $ (6,091) Other comprehensive income (loss) before reclassifications (162) 31 — (131) Amount reclassified from accumulated other comprehensive income (loss) (1) (1) — (2) Balance, September 30, 2023 $ (5,717) $ (405) $ (102) $ (6,224) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, January 1, 2024 $ (5,489) $ (445) $ (120) $ (6,054) Other comprehensive income (loss) before reclassifications (366) 68 — (298) Amount reclassified from accumulated other comprehensive income (loss) — (2) — (2) Balance, September 30, 2024 $ (5,855) $ (379) $ (120) $ (6,354) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, January 1, 2023 $ (5,926) $ (343) $ (102) $ (6,371) Other comprehensive income (loss) before reclassifications 107 (61) — 46 Amount reclassified from accumulated other comprehensive income (loss) 102 (1) — 101 Balance, September 30, 2023 $ (5,717) $ (405) $ (102) $ (6,224)

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
EARNINGS PER SHARE	Sep. 30, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Share information provided below, including references to Net income (loss) attributable to Bunge shareholders, Weighted-average number of shares outstanding, and Earnings per share have been calculated based on Bunge’s common shares prior to the Redomestication and Bunge’s registered shares after the Redomestication. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended (US$ in millions, except for share data) 2024 2023 2024 2023 Net income (loss) attributable to Bunge shareholders $ 221 $ 373 $ 535 $ 1,627 Weighted-average number of shares outstanding: Basic 140,519,185 149,195,908 141,875,297 149,958,262 Effect of dilutive shares: —stock options and awards (1) 1,626,416 2,020,948 1,696,582 1,933,552 Diluted 142,145,601 151,216,856 143,571,879 151,891,814 Earnings per share: Net income (loss) attributable to Bunge shareholders—basic $ 1.57 $ 2.50 $ 3.77 $ 10.85 Net income (loss) attributable to Bunge shareholders—diluted $ 1.56 $ 2.47 $ 3.73 $ 10.71 (1) The weighted-average shares outstanding-diluted exclude less than 1 million contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for each of the three and nine months ended September 30, 2024, and 2023.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
SEGMENT INFORMATION	Sep. 30, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company's operations are organized, managed, and classified into four reportable segments - Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy, organized based upon their similar economic characteristics, products and services offered, production processes, types and classes of customer, and distribution methods. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other. The Agribusiness segment is characterized by both inputs and outputs being agricultural commodities and thus high volume and low margin. The Refined and Specialty Oils segment involves the processing, production, and marketing of products derived from vegetable oils. The Milling segment involves the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy reportable segment primarily comprises the net earnings in the Company’s 50% interest in BP Bunge Bioenergia, a joint venture with BP p.l.c. On June 19, 2024, Bunge entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. On October 1, 2024, the transaction closed in accordance with the terms of the share purchase agreement. See Note 2 - Acquisitions and Dispositions for further information . Corporate and Other includes salaries and overhead for corporate functions that are not allocated to the Company’s individual reporting segments because the operating performance of each reporting segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities, accounts receivable securitization activities, and certain income tax assets and liabilities. Transfers between segments are generally valued at market. Segment revenues generated from these transfers are shown in the following table as “Inter-segment revenues.” Three Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 9,292 $ 3,158 $ 407 $ 38 $ 13 $ — $ 12,908 Inter–segment revenues 1,857 60 — — — (1,917) — Cost of goods sold (8,900) (2,820) (364) (37) (15) — (12,136) Gross profit 392 338 43 1 (2) — 772 Selling, general and administrative expenses (147) (103) (25) (1) (161) — (437) Foreign exchange (losses) gains – net 20 (8) — — 2 — 14 EBIT - Noncontrolling interests (1) 4 (13) — — — — (9) Other income (expense) - net 79 (14) (1) — 23 — 87 Income (loss) from affiliates (26) — — 6 — — (20) Total Segment EBIT (2) 322 200 17 6 (138) — 407 Total assets 15,911 4,018 911 391 4,036 — 25,267 Three Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 10,082 $ 3,601 $ 479 $ 56 $ 9 $ — $ 14,227 Inter–segment revenues 2,139 45 — — — (2,184) — Cost of goods sold (9,437) (3,249) (429) (54) (13) — (13,182) Gross profit 645 352 50 2 (4) — 1,045 Selling, general and administrative expenses (145) (98) (25) (1) (178) — (447) Foreign exchange (losses) gains – net (52) (2) — 1 6 — (47) EBIT - Noncontrolling interests (1) (9) (6) — — 1 — (14) Other income (expense) - net 36 (19) (2) — (7) — 8 Income (loss) from affiliates (14) — — 53 — — 39 Total Segment EBIT (2) 461 227 23 55 (182) — 584 Total assets 16,660 3,849 972 469 3,183 — 25,133 Nine Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 28,689 $ 9,519 $ 1,189 $ 130 $ 39 $ — $ 39,566 Inter–segment revenues 5,454 177 81 — — (5,712) — Cost of goods sold (27,554) (8,507) (1,020) (127) (46) — (37,254) Gross profit 1,135 1,012 169 3 (7) — 2,312 Selling, general and administrative expenses (452) (303) (74) (2) (494) — (1,325) Foreign exchange (losses) gains (81) (21) (2) — 3 — (101) EBIT - Noncontrolling interests (1) 14 (31) — — 2 — (15) Other income (expense) - net 188 (46) (4) — 74 — 212 Income (loss) from affiliates (66) — (1) 8 1 — (58) Total Segment EBIT (2) 738 611 88 9 (421) — 1,025 Total assets 15,911 4,018 911 391 4,036 — 25,267 Nine Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 31,809 $ 11,090 $ 1,484 $ 192 $ 29 $ — $ 44,604 Inter–segment revenues 6,294 138 164 — — (6,596) — Cost of goods sold (29,359) (10,063) (1,363) (188) (40) — (41,013) Gross profit 2,450 1,027 121 4 (11) — 3,591 Selling, general and administrative expenses (428) (291) (70) (1) (430) — (1,220) Foreign exchange (losses) gains (77) 8 (1) 1 5 — (64) EBIT - Noncontrolling interests (1) (29) (17) 1 — 2 — (43) Other income (expense) - net 54 (50) (5) 2 34 — 35 Income (loss) from affiliates (19) — — 119 (17) — 83 Total Segment EBIT (2) 1,951 677 46 125 (417) — 2,382 Total assets 16,660 3,849 972 469 3,183 — 25,133 (1) Includes Net (income) attributable to noncontrolling interests and redeemable noncontrolling interests adjusted for noncontrolling interests' share of interest and taxes. (2) Total Segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes Total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to Net income (loss) attributable to Bunge in the table below. A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows: Three Months Ended Nine Months Ended (US$ in millions) 2024 2023 2024 2023 Net income (loss) attributable to Bunge $ 221 $ 373 $ 535 $ 1,627 Interest income (33) (38) (112) (121) Interest expense 127 133 358 374 Income tax expense (benefit) 89 114 236 495 Noncontrolling interests' share of interest and tax 3 2 8 7 Total Segment EBIT $ 407 $ 584 $ 1,025 $ 2,382 The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging ("ASC 815") and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts with Customers ("ASC 606"). The following tables provide a disaggregation of Net sales to external customers between sales from commodity contracts (ASC 815) and sales from contracts with customers (ASC 606): Three Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 8,708 $ 292 $ — $ 36 $ — $ 9,036 Sales from contracts with customers (ASC 606) 584 2,866 407 2 13 3,872 Net sales to external customers $ 9,292 $ 3,158 $ 407 $ 38 $ 13 $ 12,908 Three Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 9,491 $ 305 $ 23 $ 53 $ — $ 9,872 Sales from contracts with customers (ASC 606) 591 3,296 456 3 9 4,355 Net sales to external customers $ 10,082 $ 3,601 $ 479 $ 56 $ 9 $ 14,227 Nine Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 27,178 $ 711 $ 1 $ 126 $ — $ 28,016 Sales from contracts with customers (ASC 606) 1,511 8,808 1,188 4 39 11,550 Net sales to external customers $ 28,689 $ 9,519 $ 1,189 $ 130 $ 39 $ 39,566 Nine Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 30,073 $ 745 $ 138 $ 187 $ — $ 31,143 Sales from contracts with customers (ASC 606) 1,736 10,345 1,346 5 29 13,461 Net sales to external customers $ 31,809 $ 11,090 $ 1,484 $ 192 $ 29 $ 44,604

BASIS OF PRESENTATION, PRINCI_2

BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Global SA ("Bunge" or the "Company"), its subsidiaries and variable interest entities ("VIEs") in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues, and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended ("Exchange Act"). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission ("SEC") rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2023 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2023, forming part of Bunge’s 2023 Annual Report on Form 10-K filed with the SEC on February 22, 2024. On November 1, 2023, Bunge Global SA completed the change of jurisdiction of incorporation of its group holding company from Bermuda to Switzerland (the "Redomestication"). The Redomestication, as approved by our shareholders, was effected pursuant to a scheme of arrangement under Bermuda law.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash
New Accounting Pronouncements and Disclosure Rules	New Accounting Pronouncements and Disclosure Rules In March 2024, the SEC adopted final climate-related disclosure rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. The rules require disclosure of governance, risk management, and strategy related to material climate-related risks as well as disclosure of material greenhouse gas emissions in registration statements and annual reports. In addition, the rules require presentation of certain climate-related disclosures in the annual consolidated financial statements. On April 4, 2024, the SEC voluntarily stayed the effective date of the final rules pending completion of judicial review following certain legal challenges. The rules are effective beginning with annual periods ending December 31, 2025, pending resolution of the stay. Bunge is currently evaluating the impact of the rules on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740) ("ASU 2023-09"). ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The new requirements apply to all entities subject to income taxes and will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company has begun evaluating disclosure presentation alternatives that will result in expanded disclosure in the Company's Income Taxes footnote. In November 2023, the FASB issued ASU 2023-07, Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280) ("ASU 2023-07"). The standard requires incremental disclosures related to reportable segments, including disaggregated expense information and the title and position of the company's chief operating decision maker, as identified for purposes of segment determination. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The Company has begun evaluating disclosure presentation alternatives that will result in expanded disclosure in the Company's Segment Information

BASIS OF PRESENTATION, PRINCI_3

BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Restricted Cash	The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows. (US$ in millions) September 30, 2024 September 30, 2023 Cash and cash equivalents $ 2,836 $ 2,173 Restricted cash included in Other current assets 53 20 Total $ 2,889 $ 2,193
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows. (US$ in millions) September 30, 2024 September 30, 2023 Cash and cash equivalents $ 2,836 $ 2,173 Restricted cash included in Other current assets 53 20 Total $ 2,889 $ 2,193

TRADE ACCOUNTS RECEIVABLE AND_2

TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM (Tables)	9 Months Ended
	Sep. 30, 2024
Transfers and Servicing [Abstract]
Schedule of Changes to the Allowance for Lifetime Expected Credit Losses Related to Trade Accounts Receivable	Changes to the allowance for expected credit losses related to Trade accounts receivable were as follows: Nine Months Ended September 30, 2024 Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term Long-term (1) Total Allowance as of January 1, 2024 $ 104 $ 32 $ 136 Current period provisions 38 1 39 Recoveries (40) (2) (42) Write-offs charged against the allowance (8) (1) (9) Foreign exchange translation differences (3) (3) (6) Allowance as of September 30, 2024 $ 91 $ 27 $ 118 (1) Long-term portion of the allowance for credit losses is included in Other non-current assets. Nine Months Ended September 30, 2023 Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term Long-term (1) Total Allowance as of January 1, 2023 $ 90 $ 46 $ 136 Current period provisions 55 — 55 Recoveries (44) (2) (46) Write-offs charged against the allowance (2) (12) (14) Foreign exchange translation differences 2 — 2 Allowance as of September 30, 2023 $ 101 $ 32 $ 133 (1) Long-term portion of the allowance for credit losses is included in Other non-current assets.
Schedule of Assets that Continue to be Recognized, Transferred Financial Assets and Other Financial Assets Managed Together	(US$ in millions) September 30, December 31, Receivables sold which were derecognized from Bunge's balance sheet $ 1,172 $ 1,230 Receivables pledged to the administrative agent and included in Trade accounts receivable $ 226 $ 343 Nine Months Ended (US$ in millions) 2024 2023 Gross receivables sold $ 8,809 $ 10,231 Proceeds received in cash related to transfers of receivables $ 8,776 $ 10,186 Cash collections from customers on receivables previously sold $ 8,868 $ 10,231 Discounts related to gross receivables sold included in Selling, general & administrative expenses $ 33 $ 45

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
INVENTORIES (Tables)	Sep. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories by Segment	Inventories by segment consist of the following: (US$ in millions) September 30, December 31, Agribusiness $ 6,163 $ 5,830 Refined and Specialty Oils 1,134 1,096 Milling 162 175 Corporate and Other 6 4 Total $ 7,465 $ 7,105 Readily marketable inventories ("RMI") are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. All other inventories are carried at lower of cost or net realizable value. RMI by segment consists of the following: (US$ in millions) September 30, December 31, Agribusiness (1) $ 5,846 $ 5,519 Refined and Specialty Oils 334 302 Milling 15 16 Total $ 6,195 $ 5,837 (1)

OTHER CURRENT ASSETS (Tables)

OTHER CURRENT ASSETS (Tables)	9 Months Ended
OTHER CURRENT ASSETS (Tables)	Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Other current assets consist of the following: (US$ in millions) September 30, December 31, Unrealized gains on derivative contracts, at fair value $ 1,025 $ 1,481 Prepaid commodity purchase contracts (1) 393 320 Secured advances to suppliers, net (2) 178 462 Recoverable taxes, net 302 378 Margin deposits 773 618 Marketable securities and other short-term investments (3) 178 105 Income taxes receivable 86 54 Prepaid expenses 194 346 Restricted cash 53 21 Other 336 266 Total $ 3,518 $ 4,051 (1) Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14- Related Party Transactions . (2) Bunge provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The balance includes certain advance payments on contracts with various unconsolidated investees see Note 14- Related Party Transactions. The Company does not bear any of the costs or operational risks associated with growing the related crops. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to suppliers are reported net of allowances of $7 million and $8 million at September 30, 2024, and December 31, 2023, respectively. (-) Interest earned on secured advances to suppliers of $4 million and $6 million for the three months ended September 30, 2024, and 2023, respectively, and $20 million and $17 million for the nine months ended September 30, 2024, and 2023, respectively, is included in Net sales in the condensed consolidated statements of income. (3) Marketable securities and other short-term investments - Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the Company's condensed consolidated balance sheets as marketable securities and other short-term investments. (US$ in millions) September 30, December 31, Foreign government securities $ 60 $ 39 Certificates of deposit/time deposits 19 — Equity securities 21 28 Other 78 38 Total $ 178 $ 105 As of September 30, 2024, and December 31, 2023, $102 million and $67 million, respectively, of marketable securities and other short-term investments were recorded at fair value. All other investments were recorded at cost, and due to the short-term nature of these investments, their carrying values approximate fair values. For the three months ended September 30, 2024, and 2023, unrealized gains/(losses) of $7 million and $(4) million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2024, and 2023. For the nine months ended September 30, 2024, and 2023, unrealized gains/(losses) of $(1) million and $(10) million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2024, and 2023.
Schedule of Marketable Securities and Other Short-Term Investments	(US$ in millions) September 30, December 31, Foreign government securities $ 60 $ 39 Certificates of deposit/time deposits 19 — Equity securities 21 28 Other 78 38 Total $ 178 $ 105

OTHER NON-CURRENT ASSETS (Table

OTHER NON-CURRENT ASSETS (Tables)	9 Months Ended
OTHER NON-CURRENT ASSETS (Tables)	Sep. 30, 2024
Other Assets, Noncurrent [Abstract]
Schedule of Other Non-Current Assets	Other non-current assets consist of the following: (US$ in millions) September 30, December 31, Recoverable taxes, net (1) $ 20 $ 25 Judicial deposits (1) 100 120 Other long-term receivables, net (2) 16 16 Income taxes receivable (1) 135 136 Long-term investments (3) 174 142 Affiliate loans receivable 8 8 Long-term receivables from farmers in Brazil, net (1) 28 43 Unrealized gains on derivative contracts, at fair value 1 1 Other 113 124 Total $ 595 $ 615 (1) A significant portion of these non-current assets arise from the Company’s Brazilian operations and their realization could take several years. (2) Net of allowances as described in Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program . (3) As of September 30, 2024, and December 31, 2023, $13 million and $12 million, respectively,
Schedule of Gross Investment in Long-Term Receivables and the Related Allowance Amounts from Brazilian Farmers	The table below summarizes the Company’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts. September 30, 2024 December 31, 2023 (US$ in millions) Recorded Allowance Recorded Allowance For which an allowance has been provided: Legal collection process (1) $ 28 $ 28 $ 30 $ 30 Renegotiated amounts — — 2 1 For which no allowance has been provided: Legal collection process (1) 11 — 19 — Renegotiated amounts (2) 4 — 5 — Other long-term receivables (3) 13 — 18 — Total $ 56 $ 28 $ 74 $ 31 (1) All amounts in legal collection processes are considered past due upon initiation of legal action. (2) These renegotiated amounts are current on repayment terms. (3) New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date. Such advances are reclassified from Other non-current assets to Other current assets in later periods depending on the expected date of their realization.
Schedule of the Activity in the Allowance for Doubtful Accounts Related to Long-Term Receivables from Brazilian Farmers	The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil. Nine Months Ended (US$ in millions) 2024 2023 Allowance as of January 1 $ 31 $ 36 Bad debt provisions 1 1 Recoveries — (3) Write-offs — (5) Transfers — — Foreign exchange translation (4) 2 Allowance as of September 30 $ 28 $ 31

INVESTMENTS IN AFFILIATES AND_2

INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES (Tables)	9 Months Ended
	Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Variable Interest Entities	For all other VIEs in which Bunge is considered the primary beneficiary, the entities meet the definition of a business, and the VIE's assets can be used other than for the settlement of the VIE’s obligations. As such, these VIEs have been excluded from the below table. (US$ in millions) September 30, December 31, Current assets: Cash and cash equivalents $ 567 $ 606 Trade accounts receivable 4 1 Inventories 47 76 Other current assets 31 146 Total current assets 649 829 Property, plant and equipment, net 368 196 Other intangible assets, net 80 91 Total assets $ 1,097 $ 1,116 Current liabilities: Trade accounts payable and accrued liabilities $ 57 $ 70 Other current liabilities 33 143 Total current liabilities 90 213 Long-term debt 47 44 Other non-current liabilities 9 5 Total liabilities $ 146 $ 262

OTHER CURRENT LIABILITIES (Tabl

OTHER CURRENT LIABILITIES (Tables)	9 Months Ended
OTHER CURRENT LIABILITIES (Tables)	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Schedule of Other Current Liabilities	Other current liabilities consist of the following: (US$ in millions) September 30, December 31, Unrealized losses on derivative contracts, at fair value $ 1,100 $ 1,038 Accrued liabilities 784 865 Advances on sales (1) 279 463 Dividends payable (2) 190 96 Income tax payable 105 238 Disposition deposit (3) 103 — Other 213 213 Total $ 2,774 $ 2,913 (1) The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less. (2) See Note 17 - Equity . (3) On June 19, 2024, Bunge entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. In the second quarter of 2024, Bunge received a refundable deposit towards the closing purchase price of $103 million. On October 1, 2024, the transaction closed in accordance with the terms of the share purchase agreement . See Note 2 - Acquisitions and Dispositions for further information.

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Sep. 30, 2024
Financial Instruments And Fair Value Measurements [Abstract]
Schedule of Hierarchy Levels that may be Used to Measure Fair Value	The fair value standard describes three levels within its hierarchy that may be used to measure fair value. Level Description Financial Instrument (Assets / Liabilities) Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities. Exchange traded derivative contracts. Marketable securities in active markets. Level 2 Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Exchange traded derivative contracts (less liquid markets). Level 3 Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities. Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques.
Schedule of Assets and Liabilities Accounted for at Fair Value on a Recurring Basis	The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis. Fair Value Measurements at Reporting Date September 30, 2024 December 31, 2023 (US$ in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 150 $ 20 $ — $ 170 $ 315 $ 149 $ — $ 464 Readily marketable inventories (Note 5) — 5,067 1,128 6,195 — 5,175 662 5,837 Trade accounts receivable (1) — 1 — 1 — 1 — 1 Unrealized gain on derivative contracts (2) : Interest rate — 13 — 13 — 12 — 12 Foreign exchange — 348 — 348 — 253 — 253 Commodities 60 449 74 583 198 737 88 1,023 Freight 45 — — 45 80 — — 80 Energy 35 — — 35 114 — — 114 Credit — 2 — 2 — — — — Other (3) 82 33 — 115 40 39 — 79 Total assets $ 372 $ 5,933 $ 1,202 $ 7,507 $ 747 $ 6,366 $ 750 $ 7,863 Liabilities: Trade accounts payable (1) $ — $ 394 $ 175 $ 569 $ — $ 591 $ 232 $ 823 Unrealized loss on derivative contracts (4) : Interest rate — 174 — 174 1 273 — 274 Foreign exchange — 276 — 276 — 223 — 223 Commodities 67 551 57 675 166 417 17 600 Freight 74 — — 74 68 — — 68 Energy 45 1 — 46 132 1 — 133 Credit — 2 — 2 — — — — Total liabilities $ 186 $ 1,398 $ 232 $ 1,816 $ 367 $ 1,505 $ 249 $ 2,121 (1) These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business. (2) Unrealized gains on derivative contracts are generally included in Other current assets. There were $1 million included in Other non-current assets at September 30, 2024, and December 31, 2023, respectively. (3) Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets. (4)
Schedule of Reconciliation of Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)	The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2024, and 2023. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant. Three Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, July 1, 2024 $ 1,262 $ 13 $ (377) $ 898 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 153 (8) 2 147 Purchases 215 — (10) 205 Sales (610) — — (610) Settlements — — 191 191 Transfers into Level 3 396 16 (68) 344 Transfers out of Level 3 (311) (4) 95 (220) Translation adjustment 23 — (8) 15 Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Three Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, July 1, 2023 $ 1,384 $ 9 $ (437) $ 11 $ 967 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 300 39 3 — 342 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — 1 1 Purchases 554 — (21) — 533 Sales (699) — — — (699) Settlements — — 158 — 158 Transfers into Level 3 450 22 (32) — 440 Transfers out of Level 3 (854) (31) 2 — (883) Translation adjustment (41) — 16 — (25) Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $207 million, $24 million and $3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $1 million mark-to-market losses related to securities still held at September 30, 2023. Nine Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, January 1, 2024 $ 662 $ 71 $ (232) $ 501 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 580 (68) 14 526 Purchases 1,594 — (438) 1,156 Sales (1,760) — — (1,760) Settlements — — 499 499 Transfers into Level 3 1,108 20 (233) 895 Transfers out of Level 3 (986) (6) 155 (837) Translation adjustment (70) — 60 (10) Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $488 million, $(50) million and $14 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2024. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Nine Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, January 1, 2023 $ 412 $ 51 $ (130) $ 27 $ 360 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 665 (32) 21 — 654 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — (1) (1) Purchases 2,767 — (450) — 2,317 Sales (2,215) — — (14) (2,229) Settlements — — 329 — 329 Transfers into Level 3 1,658 51 (113) — 1,596 Transfers out of Level 3 (2,216) (31) 44 — (2,203) Translation adjustment 23 — (12) — 11 Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $648 million, $(20) million and $22 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $15 million in mark-to-market losses related to securities still held at September 30, 2023.
Schedule of Reconciliation of Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)	The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2024, and 2023. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant. Three Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, July 1, 2024 $ 1,262 $ 13 $ (377) $ 898 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 153 (8) 2 147 Purchases 215 — (10) 205 Sales (610) — — (610) Settlements — — 191 191 Transfers into Level 3 396 16 (68) 344 Transfers out of Level 3 (311) (4) 95 (220) Translation adjustment 23 — (8) 15 Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Three Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, July 1, 2023 $ 1,384 $ 9 $ (437) $ 11 $ 967 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 300 39 3 — 342 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — 1 1 Purchases 554 — (21) — 533 Sales (699) — — — (699) Settlements — — 158 — 158 Transfers into Level 3 450 22 (32) — 440 Transfers out of Level 3 (854) (31) 2 — (883) Translation adjustment (41) — 16 — (25) Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $207 million, $24 million and $3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $1 million mark-to-market losses related to securities still held at September 30, 2023. Nine Months Ended September 30, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Total Balance, January 1, 2024 $ 662 $ 71 $ (232) $ 501 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 580 (68) 14 526 Purchases 1,594 — (438) 1,156 Sales (1,760) — — (1,760) Settlements — — 499 499 Transfers into Level 3 1,108 20 (233) 895 Transfers out of Level 3 (986) (6) 155 (837) Translation adjustment (70) — 60 (10) Balance, September 30, 2024 $ 1,128 $ 17 $ (175) $ 970 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $488 million, $(50) million and $14 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2024. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. Nine Months Ended September 30, 2023 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Trade Other (3) Total Balance, January 1, 2023 $ 412 $ 51 $ (130) $ 27 $ 360 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 665 (32) 21 — 654 Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — (1) (1) Purchases 2,767 — (450) — 2,317 Sales (2,215) — — (14) (2,229) Settlements — — 329 — 329 Transfers into Level 3 1,658 51 (113) — 1,596 Transfers out of Level 3 (2,216) (31) 44 — (2,203) Translation adjustment 23 — (12) — 11 Balance, September 30, 2023 $ 1,094 $ 39 $ (311) $ 12 $ 834 (1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $648 million, $(20) million and $22 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023. (2) Effective January 1, 2024, the Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use, which had no net impact on Level 3 readily marketable inventories period end balances. Prior period activity has been reclassified to conform to current presentation. (3) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $15 million in mark-to-market losses related to securities still held at September 30, 2023.

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Derivative Instruments	The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis. (US$ in millions) September 30, December 31, 2023 Unit of Hedging instrument type: Fair value hedges of interest rate risk Interest rate swap - notional amount $ 2,700 $ 2,900 $ Notional Cumulative adjustment to long-term debt from active application of hedge accounting $ (165) $ (260) $ Notional Carrying value of hedged debt $ 2,525 $ 2,625 $ Notional Cash flow hedges of currency risk Foreign currency forward - notional amount $ 7 $ 54 $ Notional Foreign currency option - notional amount $ 102 $ 99 $ Notional Net investment hedges Foreign currency forward - notional amount $ 1,194 $ 1,112 $ Notional The table below summarizes the volume of economic derivatives as of September 30, 2024, and December 31, 2023. For those contracts traded bilaterally through the over-the-counter markets (e.g., forwards, forward rate agreements ("FRA"), and swaps), the gross position is provided. For exchange traded (e.g., futures, FFAs, and options) and cleared positions (e.g., energy swaps), the net position is provided. September 30, December 31, 2024 2023 Unit of (US$ in millions) Long (Short) Long (Short) Interest rate Swaps $ 295 $ (1,422) $ 935 $ (1,465) $ Notional Futures $ — $ (299) $ — $ (612) $ Notional Forwards $ — $ — $ 416 $ (416) $ Notional Options $ — $ — $ — $ (3) $ Notional Currency Forwards $ 10,724 $ (11,697) $ 8,808 $ (10,356) $ Notional Swaps $ 2,759 $ (1,646) $ 1,357 $ (324) $ Notional Futures $ — $ (4) $ — $ (2) $ Notional Options $ 7 $ (33) $ 5 $ (5) Delta Agricultural commodities Forwards 22,752,408 (31,474,803) 25,588,125 (34,163,143) Metric Tons Futures — (7,590,458) — (1,224,688) Metric Tons Options 299,044 (580) 29,420 (615,937) Metric Tons Ocean freight FFA — (9,538) — (4,965) Hire Days Natural gas Forwards 500 (100) 300 — MMBtus Swaps 1,260,900 — 778,436 — MMBtus Futures 10,231,918 — 12,715,588 — MMBtus Options 507,727 — — (2,923,438) MMBtus Electricity Futures 67,321 — — (281,511) Mwh Energy - other Swaps 267,488 — 202,716 — Metric Tons Options — — 40,920 — Metric Tons Energy - CO2 Futures 245,000 — 675,000 — Metric Tons Options 400,000 — 400,000 — Metric Tons Other Swaps and futures $ 90 $ (90) $ 100 $ (106) $ Notional
Schedule of Effect of Derivative Instruments Designated as Fair Value Hedges and Undesignated Derivative Instruments on Condensed Consolidated Statements of Income	The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2024, and 2023. Gain (Loss) Recognized in Three Months Ended September 30, (US$ in millions) 2024 2023 Income statement classification Type of derivative Net sales Hedge accounting Foreign currency $ (1) $ 2 Cost of goods sold Hedge accounting Foreign currency $ — $ 1 Economic hedges Foreign currency 39 (41) Commodities (202) 30 Other (1) (37) 79 Total Cost of goods sold $ (200) $ 69 Interest expense Hedge accounting Interest rate $ (31) $ (35) Foreign exchange (losses) gains – net Hedge accounting Foreign currency $ — $ (5) Economic hedges Foreign currency (7) 10 Total Foreign exchange (losses) gains – net $ (7) $ 5 Other income (expense) Economic hedges Interest rate $ — $ (1) Other comprehensive income (loss) Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ — $ 1 Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ (18) $ 10 Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period $ (39) $ 20 Amounts released from Accumulated other comprehensive income (loss) during the period Cash flow hedge of foreign currency risk - loss/(gain) $ (1) $ (1) (1) Other includes results from freight, energy, and other derivatives. Gain (Loss) Recognized in Nine months ended September 30, (US$ in millions) 2024 2023 Income statement classification Type of derivative Net sales Hedge accounting Foreign currency $ (1) $ 6 Cost of goods sold Hedge accounting Foreign currency $ — $ 1 Economic hedges Foreign currency (160) 367 Commodities (228) 394 Other (1) (91) 86 Total Cost of goods sold $ (479) $ 848 Selling, general & administrative expenses Hedge Accounting Foreign exchange $ — $ 1 Interest expense Hedge accounting Interest rate $ (92) $ (103) Economic hedges Interest rate — 6 Total Interest expense $ (92) $ (97) Foreign exchange (losses) gains Hedge accounting Foreign currency $ — $ (26) Economic hedges Foreign currency (5) 4 Total Foreign exchange (losses) gains - net $ (5) $ (22) Other income (expense) Economic hedges Interest rate $ — $ 1 Other comprehensive income (loss) Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ — $ 1 Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period $ 4 $ (21) Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period $ 64 $ (41) Amounts released from Accumulated other comprehensive income (loss) during the period Cash flow hedge of foreign currency risk - loss/(gain) $ (2) $ (1) (1) Other includes results from freight, energy, and other derivatives

DEBT (Tables)

DEBT (Tables)	9 Months Ended
DEBT (Tables)	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Short and Long-Term Debt	The following table summarizes Bunge's short and long-term debt: (US$ in millions) September 30, December 31, Short-term debt and Current portion of long-term debt: Revolving credit facilities $ — $ — Commercial paper (1) — — Other short-term debt 755 797 Total Short-term debt 755 797 Current portion of long-term debt 663 5 Total Short-term debt and Current portion of long-term debt (2) 1,418 802 Long-term debt: (3) Term loan due 2025 - SOFR plus 0.90% (4) — 750 Term loan due 2027 - SOFR plus 1.125% 250 250 Term loan due 2028 - SOFR plus 1.325% 250 249 1.63% Senior Notes due 2025 599 598 3.25% Senior Notes due 2026 699 698 3.75% Senior Notes due 2027 598 597 4.10% Senior Notes due 2028 (5) 397 — 4.20% Senior Notes due 2029 (5) 792 — 2.75% Senior Notes due 2031 992 991 4.65% Senior Notes due 2034 (5) 790 — Cumulative adjustment to long-term debt from application of hedge accounting (189) (260) Other long-term debt 262 212 Subtotal (6) 5,440 4,085 Less: Current portion of long-term debt (663) (5) Total Long-term debt (7) 4,777 4,080 Total debt $ 6,195 $ 4,882 (1) On April 12, 2024, Bunge increased the aggregate size of its existing commercial paper program by $1 billion to an aggregate of $2 billion. (2) Includes secured debt of $207 million and $200 million at September 30, 2024, and December 31, 2023, respectively. (3) Variable interest rates are as of September 30, 2024. (4) On September 30, 2024, Bunge prepaid and terminated its 3-year term loan agreement due in 2025. (5) See Viterra Acquisition Financing section within Note 13 - Debt below for further details . (6) The fair value (Level 2) of long-term debt, including current portion, is $5,456 million and $4,125 million at September 30, 2024, and December 31, 2023, respectively. The fair value of Bunge's long-term debt is calculated based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. (7) Includes secured debt of $129 million and $100 million at September 30, 2024, and December 31, 2023, respectively.

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Tables)	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Liabilities Related to General Claims and Lawsuits Included in Other Non-Current Liabilities	Included in Other non-current liabilities as of September 30, 2024, and December 31, 2023, are the following amounts related to these matters: (US$ in millions) September 30, December 31, Non-income tax claims $ 21 $ 19 Labor claims 48 66 Civil and other claims 106 114 Total $ 175 $ 199
Schedule of Tax Examinations Against Brazilian Subsidiaries	The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable. The outstanding claims comprise the following: (US$ in millions) Years Examined September 30, 2024 December 31, 2023 ICMS 1990 to Present $ 157 $ 212 PIS/COFINS 2002 to Present $ 422 $ 438
Schedule of Recorded Liability and Maximum Potential Future Payments Related to Guarantees	Guarantees — Bunge has issued or was a party to the following guarantees at September 30, 2024: (US$ in millions) Recorded Liability Maximum Unconsolidated affiliates guarantee (1) $ 16 $ 150 Residual value guarantee (2) — 384 Russia disposition indemnity (3) 9 235 Other guarantees — 12 Total $ 25 $ 781 (1) Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, certain Bunge subsidiaries have guaranteed the obligations of certain of their unconsolidated affiliates and in connection therewith have secured their guarantee obligation s through a pledge to the financial institutions of certain of their unconsolidated affiliates' shares plus loans receivable from the unconsolidated affiliates in the event that the guaranteed obligations are enforced. Based on amounts drawn under such guaranteed debt facilities at September 30, 2024, Bunge's potential liability was $124 million, and it has recorded $16 million of obligations and potential losses related to these guarantees within Other current liabilities and Other non-current liabilities. (2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2024 through 2029. At September 30, 2024, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations. (3) On February 3, 2023, Bunge agreed to indemnify the buyer of its Russian operations against certain existing legal claims involving Bunge's Russian subsidiary. The indemnity expires on February 2, 2030. As of September 30, 2024, Bunge recorded a $9 million obligation related to this indemnity within Other non-current liabilities.

OTHER NON-CURRENT LIABILITIES (

OTHER NON-CURRENT LIABILITIES (Tables)	9 Months Ended
OTHER NON-CURRENT LIABILITIES (Tables)	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Schedule of Other Non-Current Liabilities	Other non-current liabilities consist of the following: (US$ in millions) September 30, December 31, Labor, legal, and other provisions $ 194 $ 218 Pension and post-retirement obligations (1) 153 170 Uncertain income tax positions (2) 75 68 Unrealized losses on derivative contracts, at fair value (3) 147 260 Other 101 108 Total $ 670 $ 824 (1) On October 2, 2024, the Company, as plan sponsor for one of Bunge's defined benefit U.S. pension plans, utilized approximately $377 million of plan assets to purchase an equally valued buy-in contract from a third-party insurer. On October 22, 2024, the Company notified plan participants in the same defined benefit U.S. pension plan of its intent to offer a lump sum buyout to eligible participants and terminate the plan, which is expected to be completed in the second half of fiscal year 2025. The October 2024 actions had no impact on the condensed consolidated financial statements as of September 30, 2024. (2) See Note 9 - Income Taxes. (3) See Note 11- Fair Value Measurements .

EQUITY (Tables)

EQUITY (Tables)	9 Months Ended
EQUITY (Tables)	Sep. 30, 2024
Stockholders' Equity Note [Abstract]
Schedule of Dividends Paid	Dividends on registered shares — We paid cash dividends to shareholders as follows: Three Months Ended September 30, Nine Months Ended 2024 2023 2024 2023 Dividends paid per share $ 0.68 $ 0.6625 $ 2.0225 $ 1.9125
Schedule of After-Tax Components of Accumulated Other Comprehensive Income (Loss) Attributable to Bunge	The following table summarizes the balances of related after-tax components of Accumulated other comprehensive income (loss) attributable to Bunge: (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, July 1, 2024 $ (6,005) $ (321) $ (120) $ (6,446) Other comprehensive income (loss) before reclassifications 150 (57) — 93 Amount reclassified from accumulated other comprehensive income (loss) — (1) — (1) Balance, September 30, 2024 $ (5,855) $ (379) $ (120) $ (6,354) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, July 1, 2023 $ (5,554) $ (435) $ (102) $ (6,091) Other comprehensive income (loss) before reclassifications (162) 31 — (131) Amount reclassified from accumulated other comprehensive income (loss) (1) (1) — (2) Balance, September 30, 2023 $ (5,717) $ (405) $ (102) $ (6,224) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, January 1, 2024 $ (5,489) $ (445) $ (120) $ (6,054) Other comprehensive income (loss) before reclassifications (366) 68 — (298) Amount reclassified from accumulated other comprehensive income (loss) — (2) — (2) Balance, September 30, 2024 $ (5,855) $ (379) $ (120) $ (6,354) (US$ in millions) Foreign Exchange Deferred Pension and Other Accumulated Balance, January 1, 2023 $ (5,926) $ (343) $ (102) $ (6,371) Other comprehensive income (loss) before reclassifications 107 (61) — 46 Amount reclassified from accumulated other comprehensive income (loss) 102 (1) — 101 Balance, September 30, 2023 $ (5,717) $ (405) $ (102) $ (6,224)

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
EARNINGS PER SHARE (Tables)	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Earnings per Share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended (US$ in millions, except for share data) 2024 2023 2024 2023 Net income (loss) attributable to Bunge shareholders $ 221 $ 373 $ 535 $ 1,627 Weighted-average number of shares outstanding: Basic 140,519,185 149,195,908 141,875,297 149,958,262 Effect of dilutive shares: —stock options and awards (1) 1,626,416 2,020,948 1,696,582 1,933,552 Diluted 142,145,601 151,216,856 143,571,879 151,891,814 Earnings per share: Net income (loss) attributable to Bunge shareholders—basic $ 1.57 $ 2.50 $ 3.77 $ 10.85 Net income (loss) attributable to Bunge shareholders—diluted $ 1.56 $ 2.47 $ 3.73 $ 10.71 (1) The weighted-average shares outstanding-diluted exclude less than 1 million contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for each of the three and nine months ended September 30, 2024, and 2023.

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
SEGMENT INFORMATION (Tables)	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Operating Segment Information	Segment revenues generated from these transfers are shown in the following table as “Inter-segment revenues.” Three Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 9,292 $ 3,158 $ 407 $ 38 $ 13 $ — $ 12,908 Inter–segment revenues 1,857 60 — — — (1,917) — Cost of goods sold (8,900) (2,820) (364) (37) (15) — (12,136) Gross profit 392 338 43 1 (2) — 772 Selling, general and administrative expenses (147) (103) (25) (1) (161) — (437) Foreign exchange (losses) gains – net 20 (8) — — 2 — 14 EBIT - Noncontrolling interests (1) 4 (13) — — — — (9) Other income (expense) - net 79 (14) (1) — 23 — 87 Income (loss) from affiliates (26) — — 6 — — (20) Total Segment EBIT (2) 322 200 17 6 (138) — 407 Total assets 15,911 4,018 911 391 4,036 — 25,267 Three Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 10,082 $ 3,601 $ 479 $ 56 $ 9 $ — $ 14,227 Inter–segment revenues 2,139 45 — — — (2,184) — Cost of goods sold (9,437) (3,249) (429) (54) (13) — (13,182) Gross profit 645 352 50 2 (4) — 1,045 Selling, general and administrative expenses (145) (98) (25) (1) (178) — (447) Foreign exchange (losses) gains – net (52) (2) — 1 6 — (47) EBIT - Noncontrolling interests (1) (9) (6) — — 1 — (14) Other income (expense) - net 36 (19) (2) — (7) — 8 Income (loss) from affiliates (14) — — 53 — — 39 Total Segment EBIT (2) 461 227 23 55 (182) — 584 Total assets 16,660 3,849 972 469 3,183 — 25,133 Nine Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 28,689 $ 9,519 $ 1,189 $ 130 $ 39 $ — $ 39,566 Inter–segment revenues 5,454 177 81 — — (5,712) — Cost of goods sold (27,554) (8,507) (1,020) (127) (46) — (37,254) Gross profit 1,135 1,012 169 3 (7) — 2,312 Selling, general and administrative expenses (452) (303) (74) (2) (494) — (1,325) Foreign exchange (losses) gains (81) (21) (2) — 3 — (101) EBIT - Noncontrolling interests (1) 14 (31) — — 2 — (15) Other income (expense) - net 188 (46) (4) — 74 — 212 Income (loss) from affiliates (66) — (1) 8 1 — (58) Total Segment EBIT (2) 738 611 88 9 (421) — 1,025 Total assets 15,911 4,018 911 391 4,036 — 25,267 Nine Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Eliminations Total Net sales to external customers $ 31,809 $ 11,090 $ 1,484 $ 192 $ 29 $ — $ 44,604 Inter–segment revenues 6,294 138 164 — — (6,596) — Cost of goods sold (29,359) (10,063) (1,363) (188) (40) — (41,013) Gross profit 2,450 1,027 121 4 (11) — 3,591 Selling, general and administrative expenses (428) (291) (70) (1) (430) — (1,220) Foreign exchange (losses) gains (77) 8 (1) 1 5 — (64) EBIT - Noncontrolling interests (1) (29) (17) 1 — 2 — (43) Other income (expense) - net 54 (50) (5) 2 34 — 35 Income (loss) from affiliates (19) — — 119 (17) — 83 Total Segment EBIT (2) 1,951 677 46 125 (417) — 2,382 Total assets 16,660 3,849 972 469 3,183 — 25,133 (1) Includes Net (income) attributable to noncontrolling interests and redeemable noncontrolling interests adjusted for noncontrolling interests' share of interest and taxes. (2) Total Segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes Total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to Net income (loss) attributable to Bunge in the table below.
Schedule of Reconciliation of Total Segment EBIT to Net Income Attributable to Bunge	A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows: Three Months Ended Nine Months Ended (US$ in millions) 2024 2023 2024 2023 Net income (loss) attributable to Bunge $ 221 $ 373 $ 535 $ 1,627 Interest income (33) (38) (112) (121) Interest expense 127 133 358 374 Income tax expense (benefit) 89 114 236 495 Noncontrolling interests' share of interest and tax 3 2 8 7 Total Segment EBIT $ 407 $ 584 $ 1,025 $ 2,382
Schedule of Net Sales by Product Group to External Customers	The following tables provide a disaggregation of Net sales to external customers between sales from commodity contracts (ASC 815) and sales from contracts with customers (ASC 606): Three Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 8,708 $ 292 $ — $ 36 $ — $ 9,036 Sales from contracts with customers (ASC 606) 584 2,866 407 2 13 3,872 Net sales to external customers $ 9,292 $ 3,158 $ 407 $ 38 $ 13 $ 12,908 Three Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 9,491 $ 305 $ 23 $ 53 $ — $ 9,872 Sales from contracts with customers (ASC 606) 591 3,296 456 3 9 4,355 Net sales to external customers $ 10,082 $ 3,601 $ 479 $ 56 $ 9 $ 14,227 Nine Months Ended September 30, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 27,178 $ 711 $ 1 $ 126 $ — $ 28,016 Sales from contracts with customers (ASC 606) 1,511 8,808 1,188 4 39 11,550 Net sales to external customers $ 28,689 $ 9,519 $ 1,189 $ 130 $ 39 $ 39,566 Nine Months Ended September 30, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Corporate and Other Total Sales from commodity contracts (ASC 815) $ 30,073 $ 745 $ 138 $ 187 $ — $ 31,143 Sales from contracts with customers (ASC 606) 1,736 10,345 1,346 5 29 13,461 Net sales to external customers $ 31,809 $ 11,090 $ 1,484 $ 192 $ 29 $ 44,604

BASIS OF PRESENTATION, PRINCI_4

BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES - NARRATIVE (Details) - USD ($) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Nov. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common shares, par value (in dollars per share)			$ 0.01
Registered par or stated value per share			$ 0.01
Cash paid for taxes, net of refunds	$ 333	$ 350
Cash paid for interest expense	$ 357	$ 366

BASIS OF PRESENTATION, PRINCI_5

BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES - RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 2,836	$ 2,602	$ 2,173
Restricted cash included in Other current assets	53	$ 21	20
Total	$ 2,889		$ 2,193

ACQUISITIONS AND DISPOSITIONS (

ACQUISITIONS AND DISPOSITIONS (Details) € in Millions, $ in Millions						9 Months Ended	16 Months Ended
	Oct. 01, 2024 USD ($)	Sep. 17, 2024 USD ($) tranche	Oct. 10, 2023 USD ($)	Jul. 07, 2023 USD ($) tranche	Jun. 13, 2023 USD ($) shares	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($) shares	Sep. 30, 2024 EUR (€)	Jun. 30, 2024 USD ($)	Jun. 19, 2024	Mar. 26, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Jun. 12, 2023 USD ($)	Jun. 11, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Stock repurchase program, increase in authorized amount													$ 1,700
Remaining authorized repurchase amount						$ 800	$ 800						300
Authorized amount of issued and outstanding shares available for repurchase													$ 2,000	$ 500
Repurchase of shares (in shares) \| shares							11,848,791
Repurchase of shares for the period							$ 1,200
Disposition deposit						103	103					$ 0
Investments in affiliates						1,136	1,136					1,280
Accumulated other comprehensive income (loss)						$ (6,354)	$ (6,354)					$ (6,054)
Senior Notes \| Senior Notes 0.375 Percent Due 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount \| €								€ 500
Interest rate						0.375%	0.375%	0.375%
Senior Notes \| Senior Notes 1.000 Percent Due 2028
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount \| €								€ 700
Interest rate						1%	1%	1%
BP Bunge Bioenergia
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposition deposit									$ 103
Investments in affiliates						$ 369	$ 369
Accumulated other comprehensive income (loss)						(148)	(148)
Bunge Limited Finance Corp
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Exchange offer aggregate principal amount						$ 1,950	$ 1,950
Bunge Limited Finance Corp \| Senior Notes \| Senior Notes 0.375 Percent Due 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount \| €								€ 500
Interest rate						0.375%	0.375%	0.375%
Bunge Limited Finance Corp \| Senior Notes \| Senior Notes 1.000 Percent Due 2028
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount \| €								€ 700
Interest rate						1%	1%	1%
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| BP Bunge Bioenergia
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method investment, ownership percentage										50%
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| BP Bunge Bioenergia \| Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale	$ 828
Consideration adjustment period	90 days
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| Repsol - Bunge Iberica SA
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale											$ 300
Percentage of interest to be sold											40%
Contingent consideration, liability											$ 40
Number of industrial facilities \| facility											3
CJ Latam Participacoes Ltda. and CJ Selecta S.A.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percent of interest acquired			100%
Cash consideration			$ 510
Viterra Limited \| Bunge Global SA
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest by minority shareholder					30%
Viterra Limited
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration transferred, equity interests issued and issuable (in share) \| shares					65,600,000
Transaction consideration - registered shares						$ 6,300
Cash consideration					$ 2,000
Interest acquired						100%	100%	100%
Aggregate principal amount				$ 8,000
Number of tranches \| tranche				3
Decrease in commitments		$ 2,000
Liabilities subject to compromise, early contract termination fees						$ 400	$ 400
Viterra Limited \| Senior Notes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount		$ 2,000
Number of tranches \| tranche		3
Viterra Limited \| Financing Commitment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate principal amount		$ 5,700		$ 7,700		$ 6,000	$ 6,000

TRADE STRUCTURED FINANCE PROG_2

TRADE STRUCTURED FINANCE PROGRAM (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Trade structured finance program
Weighted-average interest rate of time deposits (as a percent)	5.56%		5.77%
Total net proceeds from issuances of LCs	$ 5,200	$ 4,646
Time Deposits and LC's Presented Net in the Balance Sheet
Trade structured finance program
Face value of time deposits and LCs	$ 7,461		$ 6,880
Term to cover changes in variable rate	1 year

TRADE ACCOUNTS RECEIVABLE AND_3

TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM - Schedule of Changes to the Allowance for Lifetime Expected Credit Losses Related to Trade Accounts Receivable (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Rollforward of the Allowance for Credit Losses
Allowance, beginning balance	$ 136	$ 136
Current period provisions	39	55
Recoveries	(42)	(46)
Write-offs charged against the allowance	(9)	(14)
Foreign exchange translation differences	(6)	2
Allowance, ending balance	118	133
Short-term
Rollforward of the Allowance for Credit Losses
Allowance, beginning balance	104	90
Current period provisions	38	55
Recoveries	(40)	(44)
Write-offs charged against the allowance	(8)	(2)
Foreign exchange translation differences	(3)	2
Allowance, ending balance	91	101
Long-term
Rollforward of the Allowance for Credit Losses
Allowance, beginning balance	32	46
Current period provisions	1	0
Recoveries	(2)	(2)
Write-offs charged against the allowance	(1)	(12)
Foreign exchange translation differences	(3)	0
Allowance, ending balance	$ 27	$ 32

TRADE ACCOUNTS RECEIVABLE AND_4

TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM - NARRATIVE (Details) - Bunge Securitization B.V. $ in Billions	9 Months Ended
	Sep. 30, 2024 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Program provides funding	$ 1.5
Accordion provision	$ 1
Permit extension days	364 days

TRADE ACCOUNTS RECEIVABLE AND_5

TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM - Schedule of Assets that Continue to be Recognized, Transferred Financial Assets and Other Financial Assets Managed Together (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Accounts Receivable Securitization Facilities Disclosures
Receivables pledged to the administrative agent and included in Trade accounts receivable	$ 226		$ 343
Bunge Securitization B.V.
Accounts Receivable Securitization Facilities Disclosures
Receivables sold which were derecognized from Bunge's balance sheet	1,172		$ 1,230
Gross receivables sold	8,809	$ 10,231
Proceeds received in cash related to transfers of receivables	8,776	10,186
Cash collections from customers on receivables previously sold	8,868	10,231
Discounts related to gross receivables sold included in Selling, general & administrative expenses	$ 33	$ 45

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
INVENTORIES
Inventories	$ 7,465	$ 7,105
Readily marketable inventories at fair value	6,195	5,837
Corporate and Other
INVENTORIES
Inventories	6	4
Agribusiness \| Merchandising Activities
INVENTORIES
Readily marketable inventories at fair value	4,759	4,242
Agribusiness \| Operating
INVENTORIES
Inventories	6,163	5,830
Readily marketable inventories at fair value	5,846	5,519
Refined and Specialty Oils \| Operating
INVENTORIES
Inventories	1,134	1,096
Readily marketable inventories at fair value	334	302
Milling \| Operating
INVENTORIES
Inventories	162	175
Readily marketable inventories at fair value	$ 15	$ 16

OTHER CURRENT ASSETS - Schedule

OTHER CURRENT ASSETS - Schedule of Other Current Assets (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Other Current Assets:
Unrealized gains on derivative contracts, at fair value	$ 1,025		$ 1,025		$ 1,481
Prepaid commodity purchase contracts	393		393		320
Secured advances to suppliers, net	178		178		462
Recoverable taxes, net	302		302		378
Margin deposits	773		773		618
Marketable securities and other short-term investments	178		178		105
Income taxes receivable	86		86		54
Prepaid expenses	194		194		346
Restricted cash	53	$ 20	53	$ 20	21
Other	336		336		266
Total	3,518		3,518		4,051
Allowance on secured advance to farmers	7		7		$ 8
Interest earned on secured advances to suppliers	$ 4	$ 6	$ 20	$ 17

OTHER CURRENT ASSETS - Schedu_2

OTHER CURRENT ASSETS - Schedule of Marketable Securities and Other Short-Term Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Net Investment Income [Line Items]
Total	$ 178		$ 178		$ 105
Marketable securities and other short-term investments at fair value	102		102		67
Unrealized gain (loss) on investments	7	$ (4)	(1)	$ (10)
Foreign government securities
Net Investment Income [Line Items]
Total	60		60		39
Equity securities
Net Investment Income [Line Items]
Total	21		21		28
Other
Net Investment Income [Line Items]
Total	78		78		38
Certificates of Deposit
Net Investment Income [Line Items]
Total	$ 19		$ 19		$ 0

OTHER NON-CURRENT ASSETS - Sche

OTHER NON-CURRENT ASSETS - Schedule of Other Non-Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Recoverable taxes, net	$ 20	$ 25
Judicial deposits	100	120
Other long-term receivables, net	16	16
Income taxes receivable	135	136
Long-term investments	174	142
Unrealized gains on derivative contracts, at fair value	1	1
Other	113	124
Total	595	615
Long term investments at fair value	13	12
Affiliate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan receivable	8	8
Farmers in Brazil
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan receivable	$ 28	$ 43

OTHER NON-CURRENT ASSETS - NARR

OTHER NON-CURRENT ASSETS - NARRATIVE (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for recoverable taxes	$ 12	$ 13
Minimum initial maturity of affiliate loans receivable	1 year
Long-Term Receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average recorded investment in long-term receivables from farmers in Brazil	$ 72	$ 88

OTHER NON-CURRENT ASSETS - Sc_2

OTHER NON-CURRENT ASSETS - Schedule of Gross Investment in Long-Term Receivables and the Related Allowance Amounts from Brazilian Farmers (Details) - Long-term receivables - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Recorded Investment
Total	$ 56	$ 74
Allowance	28	31	$ 31	$ 36
Legal collection process
Recorded Investment
Recorded investment for which an allowance has been provided	28	30
Recorded investment for which no allowance has been provided	11	19
Allowance	28	30
Renegotiated amounts
Recorded Investment
Recorded investment for which an allowance has been provided	0	2
Recorded investment for which no allowance has been provided	4	5
Allowance	0	1
Other long-term receivables
Recorded Investment
Recorded investment for which no allowance has been provided	$ 13	$ 18

OTHER NON-CURRENT ASSETS - Sc_3

OTHER NON-CURRENT ASSETS - Schedule of the Activity in the Allowance for Doubtful Accounts Related to Long-Term Receivables from Brazilian Farmers (Details) - Long-term receivables - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Financing Receivable, Allowance for Credit Loss
Allowance as of January 1	$ 31	$ 36
Bad debt provisions	1	1
Recoveries	0	(3)
Write-offs	0	(5)
Transfers	0	0
Foreign exchange translation	(4)	2
Allowance as of September 30	$ 28	$ 31

INVESTMENTS IN AFFILIATES AND_3

INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES - NARRATIVE (Details) R$ in Millions, $ in Millions			9 Months Ended
	May 29, 2024 BRL (R$)	May 29, 2024 USD ($)	Sep. 30, 2024 USD ($)
Variable Interest Entity [Line Items]
Equity method investment, impairment			$ 19
Terminal XXXIX De Santos S.A. Port Facility
Variable Interest Entity [Line Items]
Equity method investment, ownership percentage	25%	25%
Payments to acquire equity method investments	R$ 300	$ 54
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Book value of investment, increase exposure to loss amount			$ 96

INVESTMENTS IN AFFILIATES AND_4

INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 2,836	$ 2,602	$ 2,173
Trade accounts receivable	2,100	2,592
Inventories	7,465	7,105
Other current assets	3,518	4,051
Total current assets	15,919	16,350
Property, plant and equipment, net	5,115	4,541
Total assets	25,267	25,372	$ 25,133
Current liabilities:
Trade accounts payable and accrued liabilities	3,211	3,664
Other current liabilities	2,774	2,913
Total current liabilities	7,691	7,687
Long-term debt	5,440	4,085
Other non-current liabilities	670	824
Variable Interest Entity, Not Primary Beneficiary
Current assets:
Cash and cash equivalents	567	606
Trade accounts receivable	4	1
Inventories	47	76
Other current assets	31	146
Total current assets	649	829
Property, plant and equipment, net	368	196
Other intangible assets, net	80	91
Total assets	1,097	1,116
Current liabilities:
Trade accounts payable and accrued liabilities	57	70
Other current liabilities	33	143
Total current liabilities	90	213
Long-term debt	47	44
Other non-current liabilities	9	5
Total liabilities	$ 146	$ 262

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 89	$ 114	$ 236	$ 495

OTHER CURRENT LIABILITIES (Deta

OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Unrealized losses on derivative contracts, at fair value	$ 1,100		$ 1,038
Accrued liabilities	784		865
Advances on sales	279		463
Dividends payable	190		96
Income tax payable	105		238
Disposition deposit	103		0
Other	213		213
Total	$ 2,774		$ 2,913
BP Bunge Bioenergia
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposition deposit		$ 103

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Accounted for at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets:
Readily marketable inventories (Note 5)	$ 6,195	$ 5,837
Unrealized gain on derivative contracts	1,025	1,481
Liabilities:
Trade accounts payable	569	823
Unrealized loss on derivative contracts	1,100	1,038
Other Noncurrent Assets
Liabilities:
Unrealized gain on derivative contracts	1	1
Other Noncurrent Liabilities
Liabilities:
Unrealized loss on derivative contracts	147	260
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets:
Cash equivalents	170	464
Readily marketable inventories (Note 5)	6,195	5,837
Trade accounts receivable	1	1
Total assets	7,507	7,863
Liabilities:
Trade accounts payable	569	823
Total liabilities	1,816	2,121
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Economic hedges
Assets:
Other	115	79
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Interest rate \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	13	12
Liabilities:
Unrealized loss on derivative contracts	174	274
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Foreign exchange \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	348	253
Liabilities:
Unrealized loss on derivative contracts	276	223
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Commodities \| Economic hedges
Assets:
Unrealized gain on derivative contracts	583	1,023
Liabilities:
Unrealized loss on derivative contracts	675	600
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Freight \| Economic hedges
Assets:
Unrealized gain on derivative contracts	45	80
Liabilities:
Unrealized loss on derivative contracts	74	68
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Energy \| Economic hedges
Assets:
Unrealized gain on derivative contracts	35	114
Liabilities:
Unrealized loss on derivative contracts	46	133
Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Credit \| Economic hedges
Assets:
Unrealized gain on derivative contracts	2	0
Liabilities:
Unrealized loss on derivative contracts	2	0
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets:
Cash equivalents	150	315
Readily marketable inventories (Note 5)	0	0
Trade accounts receivable	0	0
Total assets	372	747
Liabilities:
Trade accounts payable	0	0
Total liabilities	186	367
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Economic hedges
Assets:
Other	82	40
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Interest rate \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	1
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Foreign exchange \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Commodities \| Economic hedges
Assets:
Unrealized gain on derivative contracts	60	198
Liabilities:
Unrealized loss on derivative contracts	67	166
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Freight \| Economic hedges
Assets:
Unrealized gain on derivative contracts	45	80
Liabilities:
Unrealized loss on derivative contracts	74	68
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Energy \| Economic hedges
Assets:
Unrealized gain on derivative contracts	35	114
Liabilities:
Unrealized loss on derivative contracts	45	132
Level 1 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Credit \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets:
Cash equivalents	20	149
Readily marketable inventories (Note 5)	5,067	5,175
Trade accounts receivable	1	1
Total assets	5,933	6,366
Liabilities:
Trade accounts payable	394	591
Total liabilities	1,398	1,505
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Economic hedges
Assets:
Other	33	39
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Interest rate \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	13	12
Liabilities:
Unrealized loss on derivative contracts	174	273
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Foreign exchange \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	348	253
Liabilities:
Unrealized loss on derivative contracts	276	223
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Commodities \| Economic hedges
Assets:
Unrealized gain on derivative contracts	449	737
Liabilities:
Unrealized loss on derivative contracts	551	417
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Freight \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Energy \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	1	1
Level 2 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Credit \| Economic hedges
Assets:
Unrealized gain on derivative contracts	2	0
Liabilities:
Unrealized loss on derivative contracts	2	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets:
Cash equivalents	0	0
Readily marketable inventories (Note 5)	1,128	662
Trade accounts receivable	0	0
Total assets	1,202	750
Liabilities:
Trade accounts payable	175	232
Total liabilities	232	249
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Economic hedges
Assets:
Other	0	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Interest rate \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Foreign exchange \| Hedge accounting
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Commodities \| Economic hedges
Assets:
Unrealized gain on derivative contracts	74	88
Liabilities:
Unrealized loss on derivative contracts	57	17
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Freight \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Energy \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	0	0
Level 3 \| Assets and Liabilities Measured at Fair Value on a Recurring Basis \| Credit \| Economic hedges
Assets:
Unrealized gain on derivative contracts	0	0
Liabilities:
Unrealized loss on derivative contracts	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Sch_2

FAIR VALUE MEASUREMENTS - Schedule of Reconciliation of Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total
Balance at beginning of period	$ 898	$ 967	$ 501	$ 360
Purchases	205	533	1,156	2,317
Sales	(610)	(699)	(1,760)	(2,229)
Settlements	191	158	499	329
Transfers into Level 3	344	440	895	1,596
Transfers out of Level 3	(220)	(883)	(837)	(2,203)
Translation adjustment	15	(25)	(10)	11
Balance at end of period	970	834	970	834
Cost of goods sold
Total
Total gains and losses (realized/unrealized)	$ 147	$ 342	526	654
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income [Extensible Enumeration]	Cost of Goods and Services Sold	Cost of Goods and Services Sold
Total gains and losses (realized/unrealized) included in Other income (expense) - net
Total
Total gains and losses (realized/unrealized)		$ 1		(1)
Total gains and losses (realized/unrealized) included in Other income (expense) - net \| Marketable Securities and Investments
Trade Accounts Payable/Other
Total gains and losses (realized/unrealized)		(1)		(15)
Readily Marketable Inventories
Readily Marketable Inventories
Balance at beginning of period	$ 1,262	1,384	662	412
Total gains and losses (realized/unrealized) included in cost of goods sold	153	300	580	665
Purchases	215	554	1,594	2,767
Sales	(610)	(699)	(1,760)	(2,215)
Settlements	0	0	0	0
Transfers into Level 3	396	450	1,108	1,658
Transfers out of Level 3	(311)	(854)	(986)	(2,216)
Translation adjustment	23	(41)	(70)	23
Balance at end of period	$ 1,128	$ 1,094	$ 1,128	$ 1,094
Total
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income [Extensible Enumeration]	Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold
Changes in unrealized gains (losses) relating to Level 3 assets and liabilities	$ 124	$ 207	$ 488	$ 648
Derivatives, Net
Derivatives, Net
Balance at beginning of period	13	9	71	51
Total gains and losses (realized/unrealized) included in cost of goods sold	(8)	39	(68)	(32)
Purchases	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	16	22	20	51
Transfers out of Level 3	(4)	(31)	(6)	(31)
Translation adjustment	0	0	0	0
Balance at end of period	17	39	17	39
Total
Changes in unrealized gains (losses) relating to Level 3 assets and liabilities	$ (11)	$ 24	$ (50)	$ (20)
Derivatives, Net \| Cost of goods sold
Total
Fair value, net derivative asset (liability), recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income [Extensible Enumeration]	Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold
Trade Accounts Payable
Trade Accounts Payable/Other
Balance at beginning of period	$ (377)	$ (437)	$ (232)	$ (130)
Purchases	(10)	(21)	(438)	(450)
Sales	0	0	0	0
Settlements	191	158	499	329
Transfers into Level 3	(68)	(32)	(233)	(113)
Transfers out of Level 3	95	2	155	44
Translation adjustment	(8)	16	60	(12)
Balance at end of period	(175)	(311)	(175)	(311)
Total
Changes in unrealized gains (losses) relating to Level 3 assets and liabilities	1	3	14	22
Trade Accounts Payable \| Cost of goods sold
Trade Accounts Payable/Other
Total gains and losses (realized/unrealized)	$ 2	3	$ 14	21
Other Current Assets
Trade Accounts Payable/Other
Balance at beginning of period		11		27
Purchases		0		0
Sales		0		(14)
Settlements		0		0
Transfers into Level 3		0		0
Transfers out of Level 3		0		0
Translation adjustment		0		0
Balance at end of period		12		12
Other Current Assets \| Cost of goods sold
Trade Accounts Payable/Other
Total gains and losses (realized/unrealized)		0		0
Other Current Assets \| Total gains and losses (realized/unrealized) included in Other income (expense) - net
Trade Accounts Payable/Other
Total gains and losses (realized/unrealized)		$ 1		$ (1)

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Outstanding Derivative Instruments (Details) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024 USD ($) MMBTU MWh day t	Dec. 31, 2023 USD ($) MMBTU MWh day t
Interest rate \| Long \| Swaps
Derivative
Notional amount of derivative	$ 295	$ 935
Interest rate \| Long \| Futures
Derivative
Notional amount of derivative	0	0
Interest rate \| Long \| Forwards
Derivative
Notional amount of derivative	0	416
Interest rate \| Long \| Options
Derivative
Notional amount of derivative	0	0
Interest rate \| Short \| Swaps
Derivative
Notional amount of derivative	1,422	1,465
Interest rate \| Short \| Futures
Derivative
Notional amount of derivative	299	612
Interest rate \| Short \| Forwards
Derivative
Notional amount of derivative	0	416
Interest rate \| Short \| Options
Derivative
Notional amount of derivative	0	3
Foreign currency \| Long \| Swaps
Derivative
Notional amount of derivative	2,759	1,357
Foreign currency \| Long \| Futures
Derivative
Notional amount of derivative	0	0
Foreign currency \| Long \| Forwards
Derivative
Notional amount of derivative	10,724	8,808
Foreign currency \| Long \| Options
Derivative
Delta	7	5
Foreign currency \| Short \| Swaps
Derivative
Notional amount of derivative	1,646	324
Foreign currency \| Short \| Futures
Derivative
Notional amount of derivative	4	2
Foreign currency \| Short \| Forwards
Derivative
Notional amount of derivative	11,697	10,356
Foreign currency \| Short \| Options
Derivative
Delta	$ 33	$ 5
Agricultural commodities \| Long \| Futures
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	0
Agricultural commodities \| Long \| Forwards
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	22,752,408	25,588,125
Agricultural commodities \| Long \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	299,044	29,420
Agricultural commodities \| Short \| Futures
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	7,590,458	1,224,688
Agricultural commodities \| Short \| Forwards
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	31,474,803	34,163,143
Agricultural commodities \| Short \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	580	615,937
Ocean freight \| Long \| FFA
Derivative
Nonmonetary notional amount of derivatives (in Hire Days) \| day	0	0
Ocean freight \| Short \| FFA
Derivative
Nonmonetary notional amount of derivatives (in Hire Days) \| day	9,538	4,965
Natural gas \| Long \| Swaps
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	1,260,900	778,436
Natural gas \| Long \| Futures
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	10,231,918	12,715,588
Natural gas \| Long \| Forwards
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	500	300
Natural gas \| Long \| Options
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	507,727	0
Natural gas \| Short \| Swaps
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	0	0
Natural gas \| Short \| Futures
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	0	0
Natural gas \| Short \| Forwards
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	100	0
Natural gas \| Short \| Options
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MMBTU	0	2,923,438
Electricity \| Long \| Futures
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MWh	67,321	0
Electricity \| Short \| Futures
Derivative
Nonmonetary notional amount of derivatives (in MMBtus and Mwh) \| MWh	0	281,511
Energy - other \| Long \| Swaps
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	267,488	202,716
Energy - other \| Long \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	40,920
Energy - other \| Short \| Swaps
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	0
Energy - other \| Short \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	0
Energy - CO2 \| Long \| Futures
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	245,000	675,000
Energy - CO2 \| Long \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	400,000	400,000
Energy - CO2 \| Short \| Futures
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	0
Energy - CO2 \| Short \| Options
Derivative
Nonmonetary notional amount of derivatives (in Metric Tons) \| t	0	0
Other \| Long \| Swaps and futures
Derivative
Notional amount of derivative	$ 90	$ 100
Other \| Short \| Swaps and futures
Derivative
Notional amount of derivative	90	106
Fair value hedges \| Interest rate
Derivative
Notional amount of derivative	2,700	2,900
Cumulative adjustment to long-term debt from active application of hedge accounting	(165)	(260)
Carrying value of hedged debt	2,525	2,625
Cash Flow Hedges \| Foreign currency
Derivative
Amounts expected to be reclassified from AOCI to earnings in the next twelve months	1
Cash Flow Hedges \| Foreign currency \| Forwards
Derivative
Notional amount of derivative	7	54
Cash Flow Hedges \| Foreign currency \| Options
Derivative
Notional amount of derivative	102	99
Net Investment Hedges \| Foreign currency
Derivative
Notional amount of derivative	$ 1,194	$ 1,112

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments Designated as Fair Value Hedges and Undesignated Derivative Instruments on Condensed Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Investment Hedges
Derivative Instruments, Gain (Loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk / net investment hedges included in other comprehensive income (loss) during the period	$ (39)	$ 20	$ 64	$ (41)
Cost of goods sold
Derivative Instruments, Gain (Loss)
Gain (loss) recognized in income on derivative instruments	(200)	69	(479)	848
Interest expense
Derivative Instruments, Gain (Loss)
Gain (loss) recognized in income on derivative instruments			(92)	(97)
Foreign exchange (losses) gains – net
Derivative Instruments, Gain (Loss)
Gain (loss) recognized in income on derivative instruments	(7)	5	(5)	(22)
Foreign exchange \| Cash Flow Hedges
Derivative Instruments, Gain (Loss)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period	(18)	10	4	(21)
Cash flow hedge of foreign currency risk - loss/(gain)	(1)	(1)	(2)	(1)
Foreign exchange \| Fair value hedges
Derivative Instruments, Gain (Loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk / net investment hedges included in other comprehensive income (loss) during the period	0	1	0	1
Hedge accounting \| Foreign exchange \| Net sales
Derivative Instruments, Gain (Loss)
Gain (loss) on hedge accounting	(1)	2	(1)	6
Hedge accounting \| Foreign exchange \| Cost of goods sold
Derivative Instruments, Gain (Loss)
Gain (loss) on hedge accounting	0	1	0	1
Hedge accounting \| Foreign exchange \| Selling, general & administrative
Derivative Instruments, Gain (Loss)
Gain (loss) on hedge accounting			0	1
Hedge accounting \| Foreign exchange \| Foreign exchange (losses) gains – net
Derivative Instruments, Gain (Loss)
Gain (loss) on hedge accounting	0	(5)	0	(26)
Hedge accounting \| Interest rate \| Interest expense
Derivative Instruments, Gain (Loss)
Gain (loss) on hedge accounting	(31)	(35)	(92)	(103)
Economic hedges \| Foreign exchange \| Cost of goods sold
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges	39	(41)	(160)	367
Economic hedges \| Foreign exchange \| Foreign exchange (losses) gains – net
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges	(7)	10	(5)	4
Economic hedges \| Commodities \| Cost of goods sold
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges	(202)	30	(228)	394
Economic hedges \| Other \| Cost of goods sold
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges	(37)	79	(91)	86
Economic hedges \| Interest rate \| Interest expense
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges			0	6
Economic hedges \| Interest rate \| Other Income (Expense) - Net
Derivative Instruments, Gain (Loss)
Gain (loss) on economic hedges	$ 0	$ (1)	$ 0	$ 1

DEBT - SHORT AND LONG-TERM DEBT

DEBT - SHORT AND LONG-TERM DEBT INSTRUMENTS (Details) - USD ($) $ in Millions		9 Months Ended
	Apr. 12, 2024	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total Short-term debt		$ 755	$ 797
Current portion of long-term debt		663	5
Total Short-term debt and Current portion of long-term debt		1,418	802
Long-term debt		5,440	4,085
Less: Current portion of long-term debt		(663)	(5)
Long-term debt (Note 13)		4,777	4,080
Total debt		6,195	4,882
Level 2
Debt Instrument [Line Items]
Long-term debt		5,456	4,125
Secured Debt
Debt Instrument [Line Items]
Long-term debt (Note 13)		129	100
Term loan due 2025 - SOFR plus 0.90%
Debt Instrument [Line Items]
Long-term debt		$ 0	750
Basis spread on variable rate		0.90%
Term of credit agreement		3 years
Term loan due 2027 - SOFR plus 1.125%
Debt Instrument [Line Items]
Long-term debt		$ 250	250
Basis spread on variable rate		1.125%
Term loan due 2028 - SOFR plus 1.325%
Debt Instrument [Line Items]
Long-term debt		$ 250	249
Basis spread on variable rate		1.325%
1.63% Senior Notes due 2025
Debt Instrument [Line Items]
Long-term debt		$ 599	598
Interest rate		1.63%
3.25% Senior Notes due 2026
Debt Instrument [Line Items]
Long-term debt		$ 699	698
Interest rate		3.25%
3.75% Senior Notes due 2027
Debt Instrument [Line Items]
Long-term debt		$ 598	597
Interest rate		3.75%
4.10% Senior Notes due 2028
Debt Instrument [Line Items]
Long-term debt		$ 397	0
Interest rate		4.10%
4.20% Senior Notes due 2029
Debt Instrument [Line Items]
Long-term debt		$ 792	0
Interest rate		4.20%
2.75% Senior Notes due 2031
Debt Instrument [Line Items]
Long-term debt		$ 992	991
Interest rate		2.75%
4.65% Senior Notes due 2034
Debt Instrument [Line Items]
Long-term debt		$ 790	0
Interest rate		4.65%
Cumulative adjustment to long-term debt from application of hedge accounting
Debt Instrument [Line Items]
Cumulative adjustment to long-term debt from application of hedge accounting		$ (189)	(260)
Other long-term debt
Debt Instrument [Line Items]
Long-term debt		262	212
Revolving credit facilities
Debt Instrument [Line Items]
Total Short-term debt		0	0
Commercial paper
Debt Instrument [Line Items]
Total Short-term debt	$ 2,000	0	0
Increase in aggregate size of commercial paper	$ 1,000
Other short-term debt
Debt Instrument [Line Items]
Total Short-term debt		755	797
Secured Debt
Debt Instrument [Line Items]
Total Short-term debt and Current portion of long-term debt		$ 207	$ 200

DEBT - NARRATIVE (Details)

DEBT - NARRATIVE (Details) € in Millions	Sep. 17, 2024 USD ($) tranche	Apr. 12, 2024 USD ($)	Mar. 01, 2024 USD ($)	Feb. 29, 2024 USD ($)	Jul. 07, 2023 USD ($) tranche	Sep. 30, 2024 USD ($)	Sep. 30, 2024 EUR (€)
Bunge Limited Finance Corp
Debt Instrument [Line Items]
Exchange offer aggregate principal amount						$ 1,950,000,000
Viterra Limited
Debt Instrument [Line Items]
Aggregate principal amount					$ 8,000,000,000
Number of tranches \| tranche					3
Viterra Limited \| Delayed Draw Term Loan
Debt Instrument [Line Items]
Term of credit agreement					5 years
Aggregate principal amount					$ 300,000,000
Viterra Limited \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 2,000,000,000
Number of tranches \| tranche	3
Sale of stock, consideration received on transaction	$ 1,980,000,000
Redemption price (in percent)	101%
Viterra Limited \| Financing Commitment
Debt Instrument [Line Items]
Aggregate principal amount	$ 5,700,000,000				$ 7,700,000,000	$ 6,000,000,000
Senior Notes 4.100 Percent Due 2028 \| Viterra Limited \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 400,000,000
Interest rate	4.10%
Senior Notes 4.200 Percent Due 2029 \| Viterra Limited \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 800,000,000
Interest rate	4.20%
Senior Notes 4.650 Percent Due 2034 \| Viterra Limited \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 800,000,000
Interest rate	4.65%
Senior Notes 0.375 Percent Due 2025 \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount \| €							€ 500
Interest rate						0.375%	0.375%
Senior Notes 0.375 Percent Due 2025 \| Senior Notes \| Bunge Limited Finance Corp
Debt Instrument [Line Items]
Aggregate principal amount \| €							€ 500
Interest rate						0.375%	0.375%
Senior Notes 1.000 Percent Due 2028 \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount \| €							€ 700
Interest rate						1%	1%
Senior Notes 1.000 Percent Due 2028 \| Senior Notes \| Bunge Limited Finance Corp
Debt Instrument [Line Items]
Aggregate principal amount \| €							€ 700
Interest rate						1%	1%
Term Loan Tranche One \| Viterra Limited
Debt Instrument [Line Items]
Term of credit agreement					364 days
Term Loan Tranche Two \| Viterra Limited
Debt Instrument [Line Items]
Term of credit agreement					2 years
Term Loan Tranche Three \| Viterra Limited
Debt Instrument [Line Items]
Term of credit agreement					3 years
Revolving credit facilities \| Revolving Credit Facility Maturing March 2029 \| Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 3,200,000,000
Term of credit agreement			5 years	5 years
Option to add additional borrowing capacity, maximum amount			$ 1,500,000,000
Current borrowing capacity				$ 1,950,000,000
Incremental borrowing capacity			1,250,000,000
Revolving credit facilities \| Revolving Credit Facility Maturing October 6, 2026 \| Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 3,500,000,000
Term of credit agreement			3 years
Incremental borrowing capacity			$ 1,750,000,000
Revolving credit facilities \| Revolving Credit Facility Maturing April 11, 2025 \| Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,100,000,000
Term of credit agreement		364 days
Incremental borrowing capacity		$ 250,000,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - Related Parties - Less Than	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Supplier Concentration \| Cost of Goods Sold
Related Party Transactions
Related party composition (percent)	9%	9%	9%	9%
Supplier Concentration \| Trade Accounts Payable Benchmark
Related Party Transactions
Related party composition (percent)			3%		3%
Customer Concentration \| Net Sales
Related Party Transactions
Related party composition (percent)	2%	2%	2%	2%
Customer Concentration \| Accounts Receivable
Related Party Transactions
Related party composition (percent)			3%		3%
Customer Concentration \| Other Current Assets
Related Party Transactions
Related party composition (percent)			4%		4%
Customer Concentration \| Other Noncurrent Assets
Related Party Transactions
Related party composition (percent)			8%		8%

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Loss Contingencies and Guarantees
Claims included in Other non-current liabilities	$ 175	$ 199
Recorded Liability	25
Maximum Potential Future Payments	781
Non-income tax claims
Loss Contingencies and Guarantees
Claims included in Other non-current liabilities	21	19
Labor claims
Loss Contingencies and Guarantees
Claims included in Other non-current liabilities	48	66
Civil and other claims
Loss Contingencies and Guarantees
Claims included in Other non-current liabilities	106	114
ICMS \| Brazil \| 1990 to Present
Loss Contingencies and Guarantees
Total assessment	157	212
PIS/COFINS \| Brazil \| 2002 to Present
Loss Contingencies and Guarantees
Total assessment	422	$ 438
Unconsolidated Affiliates Financing
Loss Contingencies and Guarantees
Recorded Liability	16
Maximum Potential Future Payments	150
Potential liability	124
Obligation related to outstanding guarantees	16
Residual Value Guarantee
Loss Contingencies and Guarantees
Recorded Liability	0
Maximum Potential Future Payments	384
Obligation related to outstanding guarantees	0
Russia disposition indemnity
Loss Contingencies and Guarantees
Recorded Liability	9
Maximum Potential Future Payments	235
Obligation related to outstanding guarantees	9
Other guarantees
Loss Contingencies and Guarantees
Recorded Liability	0
Maximum Potential Future Payments	$ 12

OTHER NON-CURRENT LIABILITIES_2

OTHER NON-CURRENT LIABILITIES (Details) - USD ($) $ in Millions	Oct. 02, 2024	Sep. 30, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Labor, legal, and other provisions		$ 194	$ 218
Pension and post-retirement obligations		153	170
Uncertain income tax positions		75	68
Unrealized loss on derivative contracts, at fair value		147	260
Other		101	108
Total		$ 670	$ 824
Subsequent Event
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan	$ 377

EQUITY - NARRATIVE (Details)

EQUITY - NARRATIVE (Details) $ / shares in Units, $ in Millions		3 Months Ended					9 Months Ended		12 Months Ended	16 Months Ended	35 Months Ended
	May 15, 2024 installment	Mar. 31, 2025 $ / shares	Dec. 31, 2024 $ / shares	Sep. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 $ / shares	Sep. 30, 2023 $ / shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 $ / shares	Mar. 31, 2025 $ / shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2024 USD ($) shares	Dec. 31, 2023 USD ($)	Jun. 12, 2023 USD ($)	Jun. 11, 2023 USD ($)
Class of Stock [Line Items]
Authorized amount of issued and outstanding shares available for repurchase													$ 2,000	$ 500
Remaining authorized repurchase amount				$ 800			$ 800			$ 800	$ 800		300
Stock repurchase program, increase in authorized amount													$ 1,700
Repurchase of shares (in shares) \| shares										11,848,791
Repurchase of shares for the period										$ 1,200
Dividends declared on shares (in dollars per share) \| $ / shares				$ 0.68	$ 0.68	$ 0.6625	$ 2.72	$ 1.95
Dividends Distribution Installments \| installment	4
Dividends payable				$ 190			$ 190			$ 190	$ 190	$ 96
Forecast
Class of Stock [Line Items]
Dividends declared on shares (in dollars per share) \| $ / shares		$ 0.68	$ 0.68						$ 2.72
Shares
Class of Stock [Line Items]
Repurchase of shares (in shares) \| shares				2,063,956			6,440,930				13,957,906
Repurchase of shares for the period				$ 200			$ 600				$ 1,400

EQUITY - Schedule of Dividends

EQUITY - Schedule of Dividends Paid (Details) - $ / shares	3 Months Ended		9 Months Ended
EQUITY - Schedule of Dividends Paid (Details) - $ / shares	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Dividends paid per share (in dollars per share)	$ 0.68	$ 0.6625	$ 2.0225	$ 1.9125

EQUITY -Schedule of After-Tax C

EQUITY -Schedule of After-Tax Components of Accumulated Other Comprehensive Income (Loss) Attributable to Bunge (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
AOCI, Net of Tax [Roll Forward]
Beginning balance			$ 10,851
Other comprehensive income (loss) before reclassifications	$ 93	$ (131)	(298)	$ 46
Amount reclassified from accumulated other comprehensive income (loss)	(1)	(2)	(2)	101
Ending balance	10,135		10,135
Accumulated Other Comprehensive Income (Loss)
AOCI, Net of Tax [Roll Forward]
Beginning balance	(6,446)	(6,091)	(6,054)	(6,371)
Ending balance	(6,354)	(6,224)	(6,354)	(6,224)
Foreign Exchange Translation Adjustment
AOCI, Net of Tax [Roll Forward]
Beginning balance	(6,005)	(5,554)	(5,489)	(5,926)
Other comprehensive income (loss) before reclassifications	150	(162)	(366)	107
Amount reclassified from accumulated other comprehensive income (loss)	0	(1)	0	102
Ending balance	(5,855)	(5,717)	(5,855)	(5,717)
Deferred Gains (Losses) on Hedging Activities
AOCI, Net of Tax [Roll Forward]
Beginning balance	(321)	(435)	(445)	(343)
Other comprehensive income (loss) before reclassifications	(57)	31	68	(61)
Amount reclassified from accumulated other comprehensive income (loss)	(1)	(1)	(2)	(1)
Ending balance	(379)	(405)	(379)	(405)
Pension and Other Postretirement Liability Adjustments
AOCI, Net of Tax [Roll Forward]
Beginning balance	(120)	(102)	(120)	(102)
Other comprehensive income (loss) before reclassifications	0	0	0	0
Amount reclassified from accumulated other comprehensive income (loss)	0	0	0	0
Ending balance	$ (120)	$ (102)	$ (120)	$ (102)

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share
Net income (loss) attributable to Bunge shareholders	$ 221	$ 373	$ 535	$ 1,627
Weighted-average number of shares outstanding:
Basic (in shares)	140,519,185	149,195,908	141,875,297	149,958,262
Effect of dilutive shares:
stock options and awards (in shares)	1,626,416	2,020,948	1,696,582	1,933,552
Diluted (in shares)	142,145,601	151,216,856	143,571,879	151,891,814
Earnings per share:
Net income (loss) attributable to Bunge shareholders - basic (in dollars per share)	$ 1.57	$ 2.50	$ 3.77	$ 10.85
Net income (loss) attributable to Bunge shareholders - diluted (in dollars per share)	$ 1.56	$ 2.47	$ 3.73	$ 10.71
Stock Options and Contingently Issuable Restricted Stock Units \| Less Than
Earnings per share:
Antidilutive shares excluded from computation of EPS (in shares)	1,000,000	1,000,000	1,000,000	1,000,000

SEGMENT INFORMATION - NARRATIVE

SEGMENT INFORMATION - NARRATIVE (Details)	9 Months Ended
SEGMENT INFORMATION - NARRATIVE (Details)	Sep. 30, 2024 segment
Segment Reporting Information
Number of reportable segments	4
Sugar and Bioenergy \| BP Bunge Bioenergia
Segment Reporting Information
Equity method investment, ownership percentage	50%

SEGMENT INFORMATION - Schedule

SEGMENT INFORMATION - Schedule of Operating Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating Segment Information
Net sales	$ 12,908	$ 14,227	$ 39,566	$ 44,604
Cost of goods sold	(12,136)	(13,182)	(37,254)	(41,013)
Gross profit	772	1,045	2,312	3,591
Selling, general and administrative expenses	(437)	(447)	(1,325)	(1,220)
Foreign exchange (losses) gains – net	14	(47)	(101)	(64)
EBIT - Noncontrolling interests	(9)	(14)	(15)	(43)
Other income (expense) – net	87	8	212	35
Income (loss) from affiliates	(20)	39	(58)	83
Total segment EBIT	407	584	1,025	2,382
Total assets	25,267	25,133	25,267	25,133	$ 25,372
Operating \| Agribusiness
Operating Segment Information
Net sales	9,292	10,082	28,689	31,809
Cost of goods sold	(8,900)	(9,437)	(27,554)	(29,359)
Gross profit	392	645	1,135	2,450
Selling, general and administrative expenses	(147)	(145)	(452)	(428)
Foreign exchange (losses) gains – net	20	(52)	(81)	(77)
EBIT - Noncontrolling interests	4	(9)	14	(29)
Other income (expense) – net	79	36	188	54
Income (loss) from affiliates	(26)	(14)	(66)	(19)
Total segment EBIT	322	461	738	1,951
Total assets	15,911	16,660	15,911	16,660
Operating \| Refined and Specialty Oils
Operating Segment Information
Net sales	3,158	3,601	9,519	11,090
Cost of goods sold	(2,820)	(3,249)	(8,507)	(10,063)
Gross profit	338	352	1,012	1,027
Selling, general and administrative expenses	(103)	(98)	(303)	(291)
Foreign exchange (losses) gains – net	(8)	(2)	(21)	8
EBIT - Noncontrolling interests	(13)	(6)	(31)	(17)
Other income (expense) – net	(14)	(19)	(46)	(50)
Income (loss) from affiliates	0	0	0	0
Total segment EBIT	200	227	611	677
Total assets	4,018	3,849	4,018	3,849
Operating \| Milling
Operating Segment Information
Net sales	407	479	1,189	1,484
Cost of goods sold	(364)	(429)	(1,020)	(1,363)
Gross profit	43	50	169	121
Selling, general and administrative expenses	(25)	(25)	(74)	(70)
Foreign exchange (losses) gains – net	0	0	(2)	(1)
EBIT - Noncontrolling interests	0	0	0	1
Other income (expense) – net	(1)	(2)	(4)	(5)
Income (loss) from affiliates	0	0	(1)	0
Total segment EBIT	17	23	88	46
Total assets	911	972	911	972
Operating \| Sugar and Bioenergy
Operating Segment Information
Net sales	38	56	130	192
Cost of goods sold	(37)	(54)	(127)	(188)
Gross profit	1	2	3	4
Selling, general and administrative expenses	(1)	(1)	(2)	(1)
Foreign exchange (losses) gains – net	0	1	0	1
EBIT - Noncontrolling interests	0	0	0	0
Other income (expense) – net	0	0	0	2
Income (loss) from affiliates	6	53	8	119
Total segment EBIT	6	55	9	125
Total assets	391	469	391	469
Inter—Segment Revenues
Operating Segment Information
Net sales	(1,917)	(2,184)	(5,712)	(6,596)
Selling, general and administrative expenses	0	0	0	0
Foreign exchange (losses) gains – net	0	0	0	0
EBIT - Noncontrolling interests	0	0	0	0
Other income (expense) – net	0	0	0	0
Income (loss) from affiliates	0	0	0	0
Total segment EBIT	0	0	0	0
Total assets	0	0	0	0
Inter—Segment Revenues \| Agribusiness
Operating Segment Information
Net sales	(1,857)	(2,139)	(5,454)	(6,294)
Inter—Segment Revenues \| Refined and Specialty Oils
Operating Segment Information
Net sales	(60)	(45)	(177)	(138)
Inter—Segment Revenues \| Milling
Operating Segment Information
Net sales	0	0	(81)	(164)
Inter—Segment Revenues \| Sugar and Bioenergy
Operating Segment Information
Net sales	0	0	0	0
Corporate and Other
Operating Segment Information
Net sales	13	9	39	29
Cost of goods sold	(15)	(13)	(46)	(40)
Gross profit	(2)	(4)	(7)	(11)
Selling, general and administrative expenses	(161)	(178)	(494)	(430)
Foreign exchange (losses) gains – net	2	6	3	5
EBIT - Noncontrolling interests	0	1	2	2
Other income (expense) – net	23	(7)	74	34
Income (loss) from affiliates	0	0	1	(17)
Total segment EBIT	(138)	(182)	(421)	(417)
Total assets	$ 4,036	$ 3,183	$ 4,036	$ 3,183

SEGMENT INFORMATION -Schedule o

SEGMENT INFORMATION -Schedule of Reconciliation of Total Segment EBIT to Net Income Attributable to Bunge (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Reconciliation of total segment EBIT:
Net income (loss) attributable to Bunge	$ 221	$ 373	$ 535	$ 1,627
Interest income	(33)	(38)	(112)	(121)
Interest expense	127	133	358	374
Income tax expense (benefit)	89	114	236	495
Noncontrolling interests' share of interest and tax	3	2	8	7
Total Segment EBIT	$ 407	$ 584	$ 1,025	$ 2,382

SEGMENT INFORMATION - Schedul_2

SEGMENT INFORMATION - Schedule of Net Sales by Product Group to External Customers (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	$ 9,036	$ 9,872	$ 28,016	$ 31,143
Sales from contracts with customers (ASC 606)	3,872	4,355	11,550	13,461
Net sales to external customers	12,908	14,227	39,566	44,604
Corporate and Other
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	0	0	0	0
Sales from contracts with customers (ASC 606)	13	9	39	29
Net sales to external customers	13	9	39	29
Agribusiness \| Operating
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	8,708	9,491	27,178	30,073
Sales from contracts with customers (ASC 606)	584	591	1,511	1,736
Net sales to external customers	9,292	10,082	28,689	31,809
Refined and Specialty Oils \| Operating
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	292	305	711	745
Sales from contracts with customers (ASC 606)	2,866	3,296	8,808	10,345
Net sales to external customers	3,158	3,601	9,519	11,090
Milling \| Operating
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	0	23	1	138
Sales from contracts with customers (ASC 606)	407	456	1,188	1,346
Net sales to external customers	407	479	1,189	1,484
Sugar and Bioenergy \| Operating
Revenue from External Customer [Line Items]
Sales from commodity contracts (ASC 815)	36	53	126	187
Sales from contracts with customers (ASC 606)	2	3	4	5
Net sales to external customers	$ 38	$ 56	$ 130	$ 192